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MECHANISMS OF PRECONDITIONING AGAINST SURGICAL STRESS BY SHORT-
TERM DIETARY PROTEIN RESTRICTION 
Abstract 
Dietary restriction (DR) or reduced food intake without malnutrition encompasses a variety of 
dietary interventions including reduction of calories or specific macronutrients such as amino 
acids or total protein. Even though DR is known to result in various beneficial health effects, 
including extended longevity and increased stress resistance, the underlying nutritional and 
genetic requirements remain incompletely understood. Previous studies in lower organisms, as 
well as in mammals, point to the importance of the restriction of dietary protein intake in DR 
benefits. Previously our lab has shown that short-term restriction of intake of individual essential 
amino acids protects against hepatic ischemia reperfusion injury (IRI) via activation of the amino 
acid deprivation sensing protein, general control non-derepressible 2 (GCN2). Interestingly, 
GCN2 was no longer required for the protective effects of total dietary protein restriction (PR) 
against hepatic IRI. We thus investigated the potential role of a distinct amino acid sensing 
pathway involving the mechanistic target of rapamycin complex 1 (mTORC1) kinase, which is 
normally repressed upon PR. To test the hypothesis that reduced mTORC1 signaling is required 
for benefits of PR against hepatic IRI, we used a mouse model with liver specific deletion of the 
mTORC1 repressor gene tuberous sclerosis complex 1 (TSC1), leading to constitutive hepatic 
mTORC1 activation (LTsc1KO). Although one week of PR was able to reduce circulating 
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growth factors and amino acid levels and activate hepatic GCN2 signaling in both LTsc1KO and 
WT mice, LTsc1KO mice failed to gain the preconditioning benefits of PR against hepatic IRI. 
To understand the molecular mechanism underlying the genetic requirement for the TSC 
complex in PR benefits, we focused on the observation that PR improved hepatic insulin 
sensitivity in WT but not LTsc1KO mice. Additional data from liver specific insulin receptor 
knockout (LIrKO) mice and in WT mice using pharmacological PI3K inhibition by wortmannin 
indicated a partial requirement for post-reperfusion insulin/Akt signaling in PR-mediated 
protection from hepatic IRI. In addition to defects in insulin signaling important for PR action, 
LTsc1KOs also failed to upregulate hepatic production of another potent protective molecule, 
hydrogen sulfide (H2S), which was increased in WT mice upon PR and required for PR-mediated 
protection from hepatic IRI.  Finally, we investigated the mechanisms of regulation of hepatic 
H2S production. Using an in vitro model of increased H2S production upon serum deprivation, 
we identified growth hormone (GH) as a negative regulator of H2S production through 
JAK/STAT signaling, and increased autophagy as the likely source of free cysteine, the substrate 
for cystathionine gamma lyase (CGL)-mediated H2S production. The mechanistic details of how 
in vivo PR translates into increased H2S production, and the potential role of mTORC1, GH 
signaling and autophagy in this process remain to be fully elucidated. 
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SUMMARY 
Dietary restriction (DR), or reduced food intake without malnutrition, is associated with 
extended longevity, improved metabolic fitness and increased stress resistance in a wide range of 
organisms. DR is often referred to as calorie restriction, implying that reduced energy intake is 
responsible for its widespread and evolutionarily conserved benefits. However, recent data 
indicate dietary amino acid restriction as a key mediator of DR benefits. In fruit flies, an 
imbalance in essential amino acid intake is thought to underlie longevity benefits of DR. In 
mammals, reduced dietary protein or essential amino acid intake can extend longevity, improve 
metabolic fitness and increase stress resistance. Here we review two evolutionarily conserved 
signal transduction pathways responsible for sensing amino acid levels. The eukaryotic initiation 
factor 2-alpha (eIF2!) kinase general amino acid control non-derepressible 2 (GCN2) senses the 
absence of one or more amino acids by virtue of direct binding to uncharged cognate tRNAs. 
The presence of certain amino acids, such as leucine, permits activation of the master growth 
regulating kinase target of rapamycin (TOR). These two signal transduction pathways react to 
amino acid deprivation by inhibiting general protein translation while at the same time increasing 
translation of specific mRNAs involved in restoring homeostasis. Together, these pathways may 
contribute to the regulation of longevity, metabolic fitness and stress resistance. 
 
BACKGROUND 
Coding amino acids are necessary for protein synthesis, but are also involved in a number of 
other essential processes. For example, methionine is required for one-carbon transfer reactions; 
tryptophan is a precursor for NAD and serotonin biosynthesis; glutamate acts as a 
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neurotransmitter; and a number of amino acids can serve as intermediate metabolites in a variety 
of processes ranging from gluconeogenesis to anaplerosis. Although lower organisms can 
synthesize all of the coding (and non-coding) amino acids from carbon skeletons and nitrogen, 
some of these biosynthetic pathways were lost during evolution of multicellular organisms. Thus 
humans (as well as mice and fruit flies) must acquire the “essential” amino acids they can no 
longer synthesize through dietary means.  
Dietary restriction (DR), defined loosely as reduced food intake without malnutrition, was first 
shown to extend longevity in rats by Clive McCay in the 1930s (McCay et al., 1935). In the 
ensuing decades, lifespan extension by DR has been demonstrated in multiple species, along 
with a number of other benefits including extended healthspan, improved metabolic fitness and 
increased stress resistance. A large number of changes have been documented upon DR, 
including energy metabolism, gene expression, protein turnover, immune function and oxidative 
stress to name just a few (Masoro, 2003). However, which of these changes are evolutionarily 
conserved requirements for the benefits of DR remains unclear.  
DR is also known as calorie restriction (CR), based in part on data in rodents suggesting that the 
reduction in total calorie intake is more important than the source of those calories (e.g. 
carbohydrates vs. protein) (Ross, 1961). Recent data in fruit flies indicate that the source of the 
calories does matter, and that reduction of protein calories in the form of yeast contributes more 
to longevity extension than carbohydrate calories (Mair et al., 2005). Furthermore, adding back 
essential amino acids erases the benefits of DR on longevity extension in fruit flies (Grandison et 
al., 2009). In rodents, it has long been known that reduced dietary intake of protein or certain 
amino acids, namely methionine and tryptophan, can also extend longevity (Orentreich et al., 
1993, Segall and Timiras, 1976). What this has to do with lifespan extension by DR remains 
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unclear, as there are many similarities but also differences between rodents on DR and those on 
methionine restriction (Miller et al., 2005). 
How do cells sense the availability of amino acids, and what role might these mechanisms play 
in conveying benefits of DR? Cells have evolved different mechanisms to sense both the absence 
of individual amino acids as well as the presence of some others. Lack of amino acids is 
generally sensed by a surrogate marker, an uncharged cognate tRNA. Uncharged tRNAs then 
trigger adaptive responses through a variety of downstream mechanisms to rectify the situation. 
In bacteria, these involve direct effects on transcriptional control, while in eukaryotes uncharged 
tRNAs trigger a signal transduction pathway via direct interaction with the eukaryotic initiation 
factor 2-alpha (eIF2!) kinase general amino acid control non-derepressible 2 (GCN2). The 
presence of certain amino acids such as leucine can also be sensed, activating signal transduction 
pathways that integrate responses to environmental cues, including nutrients, through the target 
of rapamycin (TOR) kinase. Less is known about upstream amino acid sensing mechanisms in 
this pathway. A common output of amino acid deficiency sensed by either mechanism is 
repressed general translation, but enhanced (or derepressed) translation of particular mRNAs 
involved in restoring homeostasis. The mechanisms by which GCN2 activation and TOR 
repression affect translation are also distinct. Here, we will discuss both GCN2 and TOR-based 
amino acid sensing mechanisms, downstream effects on translation, and how these pathways 
may contribute to the benefits of DR including stress resistance and longevity. 
SENSING AMINO ACID DEFICIENCY: FROM UNCHARGED TRNAS TO THE 
GCN2 KINASE 
Uncharged tRNAs activate the stringent response to amino acid deprivation in bacteria  
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Protein synthesis is universally important to life as we know it, and mechanisms to sense the 
building blocks of proteins, amino acids, are conserved across evolution. In bacteria, nutrient 
deficiency activates the stringent response, so-called because of the stringent inhibition of 
transcription of stable RNAs including rRNA and tRNAs (Potrykus and Cashel, 2008). The 
stringent response is dependent on unusual nucleotides, guanosine 5’,3’ bispyrophosphate 
(ppGpp) or guanosine pentaphosphate (pppGpp), collectively referred to here as ppGpp 
(Haseltine et al., 1972, Wendrich et al., 2002). ppGpp binds to the transcriptional regulator RelA 
and modulates RNA polymerase activity in a promoter-specific fashion, downregulating some 
genes and upregulating others (Cashel et al., 1996). Although the stringent response can occur 
upon deprivation of phosphate, carbon, iron or fatty acids, it is best understood in response to 
amino acid deprivation. When intracellular amino acids are low, cognate uncharged tRNAs 
accumulate and can compete with binding of charged tRNAs to the A-site of ribosomes. When 
an uncharged tRNA occupies an A-site (Goldman and Jakubowski, 1990), translation slows and 
the ribosome-associated ppGpp synthase RelA is activated (Wendrich et al., 2002).  ppGpp,  in 
complex with the transcriptional regulator DksA, can then repress stable RNA transcription by 
binding to RNA polymerase near the active site and inhibiting its activity (Krohn and Wagner, 
1996).  At the same time, ppGpp/DksA can activate transcription of amino acid biosynthetic 
genes and suppress transcription of tRNA and rRNA genes.  
Uncharged tRNAs trigger the amino acid starvation response in eukaryotes by 
activating an eIF2α  kinase 
As in bacteria, intracellular uncharged tRNAs signal amino acid depletion in eukaryotic cells. 
Unlike bacteria, yeasts have a dedicated uncharged tRNA-sensing molecule, the signal 
transducing kinase GCN2 (Diallinas and Thireos, 1994). GCN2 has a domain with homology to 
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histidyl-tRNA synthetase (HisRS) that binds to uncharged tRNAs (Dong et al., 2000, Wek et al., 
1995), resulting in kinase activation through homodimerization and autophosphorylation 
(Diallinas and Thireos, 1994, Narasimhan et al., 2004). Beside itself, activated GCN2 has only 
one other known target, eIF2α. Phosphorylation of eIF2α prevents efficient translational 
initiation at the starting methionine codon. This slows translation of most mRNAs while at the 
same time favoring the translation of select mRNAs with specific regulatory elements in their 5’ 
untranslated regions (5’UTRs). This phenomenon of selective translational upregulation of 
specific mRNAs in the face of overall reduced global translation, known as translational 
derepression, is described in more detail in Section 4. One such derepressed mRNA encodes 
GCN4, the main effector of the general amino acid control (GAAC) pathway responsible for 
activating the transcription of amino acid biosynthetic and transport genes (Bushman et al., 1993, 
Hinnebusch, 1984). In mammals, the GCN4 ortholog controlling the transcriptional response to 
amino acid starvation, activating transcription factor 4 (ATF4), is similarly stabilized by 
translational derepression. 
Conditions leading to GCN2 activation 
In theory, any uncharged tRNA can bind the HisRS-like domain of GCN2. In yeast, a handful of 
conditions leading to accumulation of uncharged tRNAs have been experimentally verified to 
activate GCN2. These conditions include depletion of amino acids, mutation of aminoacyl tRNA 
synthetase genes or chemical inhibition leading to the accumulation of tRNAs for select amino 
acids (Wek et al., 1995). Interestingly, deprivation of a single amino acid can result in 
deacylation of non-cognate tRNAs as well. For example, leucine starvation of auxotrophic yeast 
results in accumulation of uncharged serine and threonine tRNAs in addition to leucine tRNAs 
(Zaborske et al., 2009). 
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In mammals, GCN2 can be rapidly activated in brain and liver (but apparently not kidney) upon 
ingestion of a meal lacking essential amino acids including leucine, histidine, tryptophan or 
lysine (Zhang et al., 2002, Hao et al., 2005, Anthony et al., 2004). GCN2 can also be activated 
by non-dietary depletion of amino acids (Thoreen et al., 2012). For example, in the context of an 
acute stress such as trauma or sepsis, increased nitric oxide production by NOS can rapidly 
deplete the conditional essential amino acid arginine from the blood. Local depletion of the 
essential amino acid tryptophan in the placenta by the tryptophan catabolizing enzyme 
indoleamine 2.3-dioxygenase (IDO) can anergize T cells that might otherwise react against the 
fetus. This purposeful immunosuppression is dependent on GCN2 expression in T cells (Munn et 
al., 2005). Other amino acid catabolizing enzymes such as asparaginase have been co-opted as 
chemotherapeutic agents against blood-borne cancers; the response to this agent in mice is 
dependent on GCN2 (Bunpo et al., 2009). Simulated amino acid starvation can also be achieved 
by blocking the charging of tRNAs with their cognate amino acid. Halofuginone, for example, is 
a competitive inhibitor of the prolyl-tRNA synthetase (Keller et al., 2012) that can activate the 
amino acid starvation response in vitro and in vivo (Peng et al., 2012, Sundrud et al., 2009). It is 
used to treat a variety of maladies ranging from psoriasis (an autoimmune disorder) to cancer.  
Thus, depletion of essential, non-essential, or conditionally essential amino acids by dietary, 
enzymatic or pharmacological means can activate the amino acid starvation response by 
increasing the concentration of uncharged tRNA species and activating GCN2. Because GCN2 
regulates adaptive changes to perceived amino acid deficiency, mice lacking this protein appear 
normal in the absence of such a challenge. This is not the case for one of the prime effectors of 
the GCN2 response, ATF4, which is required not only for the response to amino acid 
insufficiency, but also for the normal anabolic response to insulin, mediated at least in part 
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through the mechanistic target of rapamycin complex 1 (mTORC1) (Adams, 2007, Malmberg 
and Adams, 2008).  Cells lacking ATF4 require excess non-essential amino acids including 
cysteine (or antioxidants such as glutathione or N-acetyl cysteine)(Harding et al., 2003), and 
ATF4 knockout mice have multiple developmental abnormalities and are smaller than control 
littermates (Yang et al., 2004). 
Specificity of the GCN2-dependent amino acid starvation response 
GCN2 is one of a family of four kinases that share a common target, serine 51 of the translation 
initiation factor eIF2!. In addition to amino acid deficiency, GCN2 can also be activated by 
glucose deprivation and UV irradiation (Deng et al., 2002).  The other three eIF2! kinases are 
activated by diverse signals in different tissues, ranging from heme deficiency in erythrocytes 
(HRI) to endoplasmic reticulum stress in pancreatic B cells (PERK) to infectious or metabolic 
stress in a variety of tissues (PKR). Global translational suppression and translational 
derepression of targets such as ATF4 are not unique to GCN2-mediated eIF2α phosphorylation 
upon amino acid starvation. Nonetheless, some specificity of each response to the appropriate 
stimulus is maintained, possibly as a result of additional, unique targets (Dang Do et al., 2009). 
PKR, for example, has other direct targets besides eIF2! including protein phosphatase 2A (Xu 
and Williams, 2000). Although GCN2 has no known direct targets besides eIF2!, DNA-PK can 
be phosphorylated in a GCN2-dependent manner upon exposure of cells to UV (Powley et al., 
2009).  
SENSING AMINO ACID SUFFICIENCY: ROLE OF THE TOR SIGNAL 
TRANSDUCTION PATHWAY 
Amino acid, energy and growth factor signaling integrated through TOR 
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Our current understanding of the ability of cells to sense the presence, rather than absence, of 
specific amino acids is based on genetic and pharmacological perturbation of the signal 
transduction cascade involving the target of rapamycin (TOR) serine/threonine kinase. TOR is 
best known for controlling cell size and proliferation in response to the presence of adequate 
energy, nutrients and growth factors. TOR was first identified as the cellular target of the 
growth-inhibiting bacterial compound rapamycin, and is conserved from yeast to humans. Yeast 
has two TOR isoforms: TOR1 and TOR2, which are functionally distinct. Mammalian cells have 
a single TOR kinase, mTOR, which exists in two structurally and functionally distinct multi-
protein complexes: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). mTORC1 
is acutely inhibited by rapamycin and sensitive to nutrient levels, while mTORC2 is neither 
readily sensitive to nutrients nor acutely inhibited by rapamycin (Laplante and Sabatini, 2009).  
The kinase activity of mTORC1 is regulated by its association with the Ras-related guanosine 
triphosphatase (GTPase) Rheb (Ras homologue enriched in brain). In its GTP bound form, Rheb 
directly activates mTORC1. The Rheb specific GTPase activating protein (GAP) is the TSC2 
(tuberous sclerosis complex 2) protein, which functions as a heterotrimer with its binding 
partners TSC1 and TBC1D7 (Huang and Manning, 2008, Dibble et al., 2012). The TSC1-TSC2-
TBC1D7 complex is the critical negative regulator of mTORC1 signaling with respect to most of 
its upstream regulators such as growth factors, insulin and energy levels (Howell and Manning, 
2011). The best-characterized downstream effectors of mTORC1 signaling include eukaryotic 
initiation factor 4E (eIF4E) binding proteins 1 and 2 (4E-BP1 and 4E-BP2), and the p70 
ribosomal protein S6 kinases 1 and 2 (S6K1 and S6K2). These proteins are directly 
phosphorylated by mTORC1, and are thus commonly used as markers of TOR activity (Zoncu et 
al., 2011b). 
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Select amino acids regulate TORC1 signaling 
Amino acid levels regulate both protein synthesis and autophagic proteolysis. Evidence 
supporting the role of mTORC1 in this regulation came from cell culture studies in which 
phosphorylation of mTORC1 substrates S6K and 4EBP were associated with translational 
control and inhibition of autophagy upon amino acid stimulation (Blommaart et al., 1995, Hara 
et al., 1998, Fox et al., 1998, Xu et al., 1998, Wang et al., 1998). In rat adipocytes, addition of 
amino acids to the media stimulates S6K phosphorylation, which is sensitive to rapamycin 
treatment (Fox et al., 1998). In Chinese hamster ovary (CHO) cells, amino acid withdrawal 
results in a rapid dephosphorylation of S6K and 4EBP1 and abolishes the ability of growth 
factors to stimulate S6K activity. Re-addition of single amino acid dropout mixtures lacking 
leucine or arginine reduces S6K activity by 90% or 70%, respectively (Hara et al., 1998). 
Interestingly, readdition of either leucine or arginine individually is unable to stimulate S6K 
activity.   
Similar studies carried out in different contexts and cell types, including H4IIE hepatoma, L6 
muscle and pancreatic " cells, revealed important details about the regulatory properties of 
individual amino acids on TOR activity. All agreed on the prominent role of leucine (Shigemitsu 
et al., 1999, Xu et al., 1998, Krause et al., 2002, Peyrollier et al., 2000). However, in certain 
contexts arginine stimulates S6K activity (Nakajo et al., 2005), while in others each of the 
branched chain amino acids (leucine, isoleucine and valine) has similar potency in stimulating 
4EBP1 phosphorylation (Xu et al., 1998). The non-essential amino acid glutamine can also 
modulate leucine and arginine-stimulated mTORC1 signaling, although in different directions in 
different cell types. In rat intestinal epithelial cells and myogenic C2C12 cells, glutamine 
antagonizes arginine and leucine-mediated mTORC1 activation, respectively (Nakajo et al., 2005, 
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Ban et al., 2004, Deldicque et al., 2008). In isolated rat hepatocytes, leucine and glutamine work 
additively to increase mTORC1 signaling (Krause et al., 2002). In HeLa cells, the interaction 
between glutamine and leucine has been ascribed to a heterodimeric, bidirectional amino acid 
antiporter consisting of solute carrier family 7 member 5/solute carrier family 3 member 2 
(SLC7A5/SLC3A2) that regulates the simultaneous efflux of glutamine and influx of leucine and 
other essential amino acids (Nicklin et al., 2009). Interestingly, in a recent study, carried out in a 
variety of cell types, it was shown that leucine and glutamine cooperate to activate mTORC1 
signaling, through enhancing glutaminolysis and !-ketoglutarate production (Duran et al., 2012). 
In yeast auxotrophs, deprivation of leucine (and to a lesser degree lysine and histidine) reversibly 
inhibits TORC1-dependent phosphorylation of Sch9 (the yeast ortholog of S6K). Inhibition of 
protein synthesis with cyclohexamide results in accumulation of intracellular free amino acids, 
with leucine accumulating more than others, and increases Sch9 phosphorylation (Binda et al., 
2009). Together these observations are consistent with leucine primacy in TOR activation 
crossing evolutionary boundaries. 
Bridging the gap between leucine sensing and TOR activation 
Unlike the GCN2 pathway, the most upstream mechanisms directly responsible for amino acid 
sensing permissive of TOR activation, and even the subcellular compartment in which this 
occurs, remain unresolved. TOR itself does not appear to bind amino acids or surrogates such as 
cognate tRNAs as GCN2 does. A number of candidates have been proposed as intermediates in 
TOR activation by amino acids. Some initial studies suggested a role of TSC1/TSC2 in amino 
acid sensing. However, budding yeast don’t have TSC proteins, and mammalian TSC1 or TSC2 
null cells are still sensitive to amino acid withdrawal, suggesting that amino acids signal to 
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mTORC1 independently of TSC1/TSC2 (Smith et al., 2005, Huang and Manning, 2008). Human 
vacuolar protein-sorting 34 (hVps34) has also been proposed to participate in amino acid sensing. 
This class III PI3-kinase participates in the regulation of mTORC1 by amino acids, possibly 
through its effects on vesicle trafficking and/or through generation of membrane compartments 
necessary for mTORC1 activation (Dann and Thomas, 2006, Avruch et al., 2009).  
Two independent groups, using complementary biochemical and genetic approaches, showed 
that the Rag family of small GTPases is required for amino acid sensing by mTORC1 (Sancak et 
al., 2008, Kim et al., 2008). Rag GTPases are orthologs of  the yeast Gtr1p and Gtr2p GTPases, 
which function as obligate heterodimers and regulate the Gap1 amino acid permease and 
microautophagy. The critical role of Rags in mTORC1 signaling and its regulation of cellular 
growth is further evidenced by in vivo experiments in Drosophila, where constitutively active 
RagA leads to flies with increased cell and wing size, whereas dominant negative RagA leads to 
flies with decreased wing size (Kim et al., 2008). Mammalian Rags also exist in heterodimers 
with one Gtr1p-like (RagA or RagB) and one Gtr2p-like (RagC or RagD) partner (Shaw, 2008). 
Unlike the Rheb GTPase, purified Rag GTPases are unable to stimulate mTORC1 kinase activity 
in vitro (Kim et al., 2008).  
Instead, Rag-mediated mTORC1 activation involves recruitment of the complex to the outer 
lysosomal membrane, where it can interact with its activator Rheb (Sancak et al., 2008, Sancak 
et al., 2010). The Rag heterodimer is anchored to the lysosomal membrane via the protein 
complex called “Ragulator” (Sancak et al., 2010, Efeyan et al., 2012) and activated by the 
presence of amino acids. RagA/B in its GTP-bound form with Rag C/D in its GDP-bound form 
constitutes the active heterodimer, which recruits mTORC1 to the lysosomal membrane through 
an interaction with Raptor. The Ragulator complex is functionally analogous to the yeast EGO 
 13 
complex due to its interaction with Gtr1p and Gtr2p, and its regulation of amino acid signaling to 
TOR at the vacuolar membrane (Binda et al., 2009, Sancak et al., 2010). Thus, spatial regulation 
of the mTORC1 complex has emerged as an important aspect of amino acid-mediated control 
(Suzuki and Inoki, 2011). 
Lysosomes/vacuoles are a major site of protein degradation and amino acid recycling with high 
concentrations of free amino acids. Based on mTORC1 localization and activation at the 
cytoplasmic face of the lysosomal membrane, the relevant amino acid sensing mechanism has 
been proposed to sense lysosomal rather than cytoplasmic free amino acid pools (Sancak et al., 
2010). A Drosophila siRNA screen targeting the lysosomal components that might be involved 
in amino acid signaling to TOR revealed the requirement of vacuolar ATPase (V-ATPase), and 
this was confirmed in mammalian cells (Zoncu et al., 2011a). Although the ATPase activity of 
V-ATPase is required for amino acid permissive signaling, V-ATPase does not function in 
transport of amino acids between the cytoplasm and the lysosome.  V-ATPase does, however, 
appear to function upstream of the Rag-Ragulator interaction, in which amino acids stimulate 
guanine nucleotide exchange factor (GEF) activity of the pentameric Ragulator complex toward 
RagA and RagB (Bar-Peled et al., 2012). In further support of the importance of lysosomal free 
amino acid pools, stimulation of amino acid starved cells with radioactively labeled amino acids 
leads to their rapid appearance in the lysosome (Zoncu et al., 2011a). 
At face value, this lysosome-centered rather than cytoplasmic-centered view of amino acid 
sensing appears to be at odds with a recent report identifying the leucyl-tRNA synthetase as the 
intracellular leucine sensor responsible for mTORC1 activation (Han et al., 2012). siRNA 
directed at the leucyl-tRNA synthetase renders 293T cells unable to phosphorylate S6K in 
response to leucine or isoleucine withdrawal and restimulation. Consistent with its requirement 
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for leucine permissive mTORC1 activation, the leucyl-tRNA synthetase also localizes to the 
cytoplasmic face of the lysosomal membrane, interacts with the Rag GTPase and has GAP 
activity specifically toward RagD, promoting the active GDP-bound form in the presence of 
leucine. Its ability to stimulate mTORC1 is dependent on leucine binding, but is independent of 
its ability to charge leucine tRNA. Nonetheless, the subcellular localization of the free leucine, 
and whether other TOR-permissive amino acids such as arginine function through similar 
mechanisms, remain to be seen. 
MECHANISMS OF GCN2 VS. TOR BASED TRANSLATIONAL CONTROL  
Translation of mRNA is one of the most energy requiring processes in the cell. It must therefore 
be coupled to the availability of cellular energy and coding amino acids. The immediate response 
to energy or amino acid insufficiency is to repress translation. At the same time, cells increase 
translation of specific messages involved in metabolic adaptation, for example transcription 
factors controlling the expression of amino acid biosynthetic and transport genes.  This process is 
known as translational derepression. Just as GCN2 and TOR pathways sense amino acids by 
different mechanisms, so do they differ in the ways they accomplish translational repression and 
derepression (Figure 1.1).  
Translational regulation by GCN2 
Translation initiation occurs upon pairing of the AUG start codon with an initiator methionyl-
tRNA (Met-tRNAiMet ), which is part of the so-called ternary complex together with eIF2 and  
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Figure 1.1 Integration of amino acid sensing with translational control. Two signal 
transduction mechanisms are involved in sensing intracellular amino acids: GCN2 senses the 
absence of many amino acids; the TOR pathway senses the presence of particular amino acids. 
Both repress general translation and derepress translation of specific messages through distinct 
mechanisms. EAA, essential amino acid. BCAA, branched chain amino acid. 
  
 16 
GTP. This is followed by hydrolysis of eIF2-bound GTP and release of eIF2-GDP from the 43S 
ribosome. Phosphorylation of the α subunit of eIF2 by GCN2 inhibits GDP/GTP exchange by 
eIF2B, reducing ternary complex availability and thus repressing initiation of translation of most 
mRNAs.  
Some mRNAs, however, contain short upstream open reading frames, or micro (µ)ORFs, that 
influence translation of the downstream full-length ORF depending on the status of eIF2! 
phosphorylation. Reinitiation of translation following µORF translation requires reassociation of 
the ternary complex. This depends both on the concentration of ternary complex (and hence 
eIF2! phosphorylation status) and the scanning distance/time to the next AUG codon. Increasing 
the distance between µORFs increases the chance of ternary complex association before reaching 
the next AUG start codon (Abastado et al., 1991). Under non-starvation conditions, reinitiation 
of translation after the first µORF is relatively efficient, decreasing the chance of translation of 
the downstream full-length ORF. Under amino acid starvation conditions, reinitiation after the 
first µORF is less efficient, increasing the chance that the ribosome will scan past subsequent 
µORFs and reinitiate translation further downstream at the full-length ORF. Thus, the distance 
between µORFs and timing of ribosomal reinitiation are critical factors in translational 
derepression of mRNAs such as GCN4 upon intracellular amino acid starvation. Stabilization of 
ATF4 occurs by a similar mechanism (Vattem and Wek, 2004), indicating conservation of this 
simple yet elegant translational program from yeast to mammalian cells.   
Translational regulation by mTOR 
The mTORC1 pathway controls protein synthesis most directly by phosphorylating and 
inhibiting a repressor of cap-dependent mRNA translation, 4EBP-1. Translation of most cellular 
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mRNAs is initiated via this common mechanism involving assembly of the eukaryotic initiation 
factor 4F complex (eIF4F, comprised of eIF4E, eIF4G and eIF4A) on the 5’ 7-methyl-GTP cap. 
eIF4F is required for the loading of the small ribosomal subunit on the mRNA. 4EBPs repress 
translation by inhibiting the formation of the eIF4F complex (Ma and Blenis, 2009). 
Phosphorylation of 4EBPs by mTORC1 results in their dissociation from eIF4E, facilitating cap-
dependent translation (Huang and Manning, 2008). Acute inhibition of mTORC1 with 
rapamycin, or the more potent inhibitor Torin 1, reduces protein synthesis by approximately 30% 
or 60%, respectively, without affecting the status of eIF2! phosphorylation (Thoreen et al., 2012). 
Torin 1 inhibits translation of nearly all (99.8%) cellular mRNAs, but the magnitude of 
repression is greatest for mRNAs containing 5’ terminal oligopyrimidine (TOP) motifs in their 
5’UTRs. Importantly, this class of mRNAs encode all ribosomal proteins and major translation 
factors, therefore influencing the protein synthetic capacity of the cell. Torin 1-mediated 
translation repression requires 4EBPs and is lost in cells lacking these proteins (Thoreen et al., 
2012).  
mTORC1 also regulates translation indirectly through phosphorylation of S6K. Phosphorylation 
on Thr389 activates S6K toward ribosomal protein S6, a component of the 40S ribosome 
important for translation in rapidly proliferating cells. It also phosphorylates a number of other 
downstream targets including eIF4B, eukaryotic translation elongation factor 2 kinase (eEF2K), 
and SKAR (Ma and Blenis, 2009). Phosphorylation of S6K targets can promote translation by a 
variety of direct and indirect mechanisms, including regulation of eIF4B recruitment, inhibition 
of PDCD-4 mediated inhibition of eIF4A, splicing-dependent translation of some mRNA 
messages via SKAR, and regulation of ribosome biogenesis (Ma et al., 2008, Richardson et al., 
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2004). The ability of amino acids to regulate phosphorylation of both S6K and 4EBPs was 
evidenced in early studies (Xu et al., 1998).   
While mTORC1 inhibition represses cap-dependent translation, it also selectively derepresses 
translation of select mRNAs that don’t depend on cap-binding for ribosome entry. Conceptually, 
this parallels translational derepression upon GCN2 activation. However, instead of a µORF, it 
depends on an internal ribosome entry site (IRES) in the 5’UTR for cap-independent ribosome 
recruitment. IRES-containing mRNAs are not only resistant to mTORC1 inhibition by Torin 1, 
but are in fact translated with greater efficiency under such conditions (Thoreen et al., 2012).  
IRES-containing mRNAs are often involved in the response to stress, for example NF-E2 related 
factor 2 (NRF2), the master transcriptional regulator of genes in the Phase II response to 
oxidative/electrophilic stress. NRF2 is translationally upregulated during oxidative stress despite 
the attenuation of global protein synthesis due to an IRES-dependent mechanism (Li et al., 2010, 
Purdom-Dickinson et al., 2007). However, whether NRF2 is translationally derepressed upon 
amino acid starvation or mTORC1 inhibition remains to be elucidated.  
Protein deficiency is expected to simultaneously repress mTOR and activate GCN2. How can 
efficient translational derepression occur when mRNA cap-binding and translation initiation are 
both inhibited by mTORC1 repression and GCN2 activation, respectively? One possibility is that 
mRNAs subject to control by GCN2/eIF2! lack TOP motifs, limiting the effect of 
mTORC1/4EBP-based repression on cap-binding. Another possibility is that IRES-containing 
mRNAs also contain µORFs; cationic amino acid transporter 1 (CAT1) is an example of such an 
mRNA (Kilberg et al., 2009). IRES-mediated translational derepression can also occur despite 
phosphorylation of eIF2!. For example, translation of X-chromosome linked Inhibitor of 
Apoptosis (XIAP) occurs via an eIF2!-independent mechanism of translation initiation 
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dependent on eIF5B (Thakor and Holcik, 2012). Thus, translational derepression likely depends 
both on features within a particular 5’UTR as well as the status of both GCN2 and TOR activity. 
COORDINATION OF AMINO ACID STARVATION RESPONSES THROUGH GCN2 
AND TOR  
Why did separate amino acid sensing pathways evolve together in eukaryotes? Are they 
redundant or do they play separate roles? What is the connection between the two? Amino acid 
sensing through the TOR pathway may have evolved primarily to coordinate information on the 
presence of adequate nutrients (including amino acids), energy and other environmental 
conditions favorable for growth. Leucine and the other branched chain amino acids (BCAAs) are 
abundant in a variety of proteins. In mammals, they are also the only free amino acids to increase 
in peripheral blood after a meal in proportion to their levels in the diet (the remaining 17 are 
retained in the gut and liver and released in a controlled fashion) (Layman, 2003). These 
qualities of BCAAs may be advantageous for a surrogate marker of availability of all amino 
acids.  
GCN2-based sensing of individual amino acid deficiencies may have evolved for different 
reasons. Dietary amino acid deficiencies are common and must be detected rapidly in order to 
avoid negative effects ranging from reduced growth to fatty liver (Harper et al., 1970). Protein 
sources with amino acid deficiencies include rice (low amounts of the essential amino acid 
lysine), casein (limiting for both tryptophan and methionine) and gelatin (lacks tryptophan 
altogether). Xenobiotic antimetabolites targeting individual amino acid metabolic pathways (for 
example, tRNA synthetase inhibitors) may also be widespread in nature. Interestingly, yeast can 
make all 20 coding amino acids, and thus don’t activate the GAAC response when amino acids 
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are absent (for example in minimal growth media) (Hinnebusch, 2005). However, they do 
activate the response when individual amino acids are deficient or in the presence of tRNA 
synthetase inhibitors. Thus, the GCN2-based GAAC response may have evolved under different 
selective pressures than the TOR-based response, although both function to optimize growth 
potential and prioritize metabolic demands to fit environmental conditions. 
Are responses to amino acid deprivation through GCN2 and TOR coordinated? In yeast, GCN4 
translation is derepressed upon inhibition of TOR with rapamycin in a GCN2 and TOR1-
dependent fashion (Kubota et al., 2003). Mechanistically, TOR inhibition may reduce inhibitory 
phosphorylation of GCN2, thus promoting eIF2! phosphorylation and GCN4 translational 
derepression. GCN4 is also a major effector of the transcriptional response to TOR inhibition by 
rapamycin on a scale equivalent to the canonical transcriptional activator and TOR substrate 
GLN3 (Staschke et al., 2010, Cherkasova and Hinnebusch, 2003). Genes co-regulated by both 
GCN4 and GLN3 include those involved in nitrogen assimilation, amino acid transport, amino 
acid biosynthesis, and other transcriptional activators.  
Crosstalk between GCN2 and mTOR also exists in mammalian cell culture and animal models, 
although the direction of interaction appears to be different than in yeast. In human lymphocytic 
leukemic cell lines, treatment with L-asparaginase, an enzyme that degrades asparagine in 
culture medium and activates GCN2, inhibits mTORC1 phosphorylation of its targets S6K and 
4EBP1 in a dose-dependent fashion (Iiboshi et al., 1999a). Likewise, S6K activity is reduced in 
human T-lymphoblastoid cells exposed to various amino acid alcohols that selectively inhibit 
specific tRNA loading, including L-histidinol, L-leucinol, L-phenylalaninol, and L-methioninol 
(Iiboshi et al., 1999b). Both studies suggest crosstalk between GCN2 and mTORC1 signaling, 
with uncharged tRNAs initiating the changes in signal transduction. 
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Genetic evidence in mice is also consistent with GCN2 activation occurring upstream of 
mTORC1 repression. In response to dietary leucine deprivation or asparaginase treatment, 
phosphorylation of mTORC1 targets S6K and 4EBP1 are reduced in the liver and pancreas, and 
this depends on the GCN2 kinase (Bunpo et al., 2009, Anthony et al., 2004). Leucine-deficient 
diets also improve insulin signaling in the liver as measured by increased phosphorylation of the 
insulin receptor, and whole-body insulin sensitivity as measured by an insulin tolerance test 
(Xiao et al., 2011). However, in GCN2 KO mice on a leucine deficient diet, mTOR signaling in 
liver is increased and the improvement in insulin sensitivity is lost. Interestingly, GCN2 KO 
mice on a leucine deficient diet also develop hepatic steatosis due to increased expression of 
SREBP-1c dependent lipogenic genes including FAS, ACL, and G6PD, which are under control 
of mTORC1 in the liver. This suggests a model in which failure to repress mTORC-1 allows 
inappropriate activation of SREPB-1c targets (Guo and Cavener, 2007, Yecies et al., 2011).  
Potentially complicating this model is the fact that leucine deprivation on its own would be 
predicted to reduce mTORC1 activity by GCN2 independent mechanisms. Nonetheless, taken 
together these findings are consistent with a model in which GCN2 activation by 
pharmacological or dietary means can suppress mTORC1 activity. 
AMINO ACID SENSING IN DIETARY RESTRICTION BENEFITS 
Dietary protein/amino acid modulation and longevity  
DR has been intricately associated with aging research since the discovery in the 1930s that 
reduced food intake extends longevity of experimental rodents (McCay et al., 1935). Today, we 
know that the benefits of DR occur in a variety of organisms and are pleiotropic in nature. These 
benefits include enhanced metabolic fitness and improved resistance to multiple forms of acute 
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stress, ranging from heat shock to surgical ischemia reperfusion injury. Still, lifespan extension 
in a variety of model organisms is the most studied and perhaps best understood of its pleiotropic 
benefits.  
Classically, DR has been described as reduced food intake without malnutrition. DR is not a 
single intervention but it rather loosely describes a variety of interventions ranging widely in 
both dietary composition and timing of food intake (Mair and Dillin, 2008). Despite a number of 
studies aimed at dissecting the nutritional basis of DR, no consensus yet exists on the relative 
contributions of overall reduced calorie intake vs. the restriction of particular macronutrients 
such as protein (Mair et al., 2005).  
In yeast, in addition to deletion of TOR1 or Sch9, inhibition of glutamine synthetase and 
rapamycin treatment, chronological lifespan can be extended by restriction of asparagine, 
glutamate or methionine in the media (Dilova et al., 2007). Unfortunately in worms, another 
well-characterized model organism in which the genetics of longevity extension and DR are 
particularly well characterized, the lack of purified diets and the ability of starvation to increase 
the lifespan of adults makes these questions difficult to address.  
In fruit flies, reduction of the calories via titration of the sole source of protein, yeast extract, 
provides greater longevity extension than isocaloric reduction of sucrose (Mair et al., 2005). 
Adding back purified essential amino acids (EAA) to a restricted sucrose/yeast-based diet 
optimized for longevity abrogates lifespan extension, while adding back EAA minus methionine 
(or to a lesser degree tryptophan) does not (Grandison et al., 2009). Perhaps most unexpectedly, 
adding back methionine alone (but not other individual EAA) on top of the DR regimen 
abrogated a well-known negative consequence of DR, reduced fecundity. While the involvement 
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of reduced insulin-like peptide signaling is implicated in longevity benefits  (Grandison et al., 
2009), the status of GCN2 under conditions of DR and EAA add-back remains to be reported.  
In rodents, a number of studies have reported moderate lifespan extension upon dietary protein 
restriction as with DR (Pamplona and Barja, 2006). However, interpretation of DR and protein 
restriction studies are both complicated by the fact that protein and carbohydrates are readily 
interconverted in vivo. A different approach was to reduce individual dietary essential amino 
acids, namely tryptophan and methionine. It is not clear why only these two have been tested in 
rodents for longevity benefits. In the case of tryptophan, there is some evidence of increased 
maximal lifespan and a delay in aging-related phenotypes in at least a subset of tryptophan-
restricted rats (Segall and Timiras, 1976, Ooka et al., 1988). The underlying mechanistic 
hypothesis in these studies involved reduction of serotonin, a downstream metabolite of 
tryptophan. Likewise, methionine restriction has been shown to extend lifespan in male rats and 
mice (Orentreich et al., 1993, Miller et al., 2005).  
Interestingly, tryptophan and methionine are the two least abundant essential amino acids by 
weight in casein, a protein commonly used in purified diets for experimental rodents. Thus, DR 
regimens using casein as the sole source of protein would be expected, at some level of 
restriction, to become limited for these two essential amino acids. Indeed, there are many 
overlapping phenotypes shared both by DR and isolated methionine restriction, including 
reduced adiposity, extended maximal longevity, increased resistance to acetaminophen toxicity 
in the liver, reduced insulin and IGF1 levels and reduced thyroid hormone (Miller et al., 2005). 
Nonetheless, there are differences as well, and future studies will be necessary to address 
whether the benefits of each are derived from fundamentally distinct or overlapping mechanisms.  
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To the best of our knowledge, other amino acid restricted diets have not been tested for lifespan 
extension, but have been shown to induce a number of other benefits. For example, methionine 
restriction contributes to adiposity resistance by altering the lipogenic/lipolytic balance (Perrone 
et al., 2008), leucine deprivation improves insulin sensitivity (Xiao et al., 2011) and tryptophan 
deprivation protects against surgical ischemia reperfusion injury to both kidney and liver (Peng 
et al., 2012). The latter two benefits are absent in mice lacking GCN2. 
Role of GCN2 and TOR in protein/amino acid restriction benefits 
What roles do the TOR and/or GCN2 signal transduction pathways play in regulating longevity, 
metabolic fitness and stress resistance upon restriction of protein or specific amino acids? There 
is ample evidence that reduction of TOR signaling through genetic or pharmacological 
manipulation can extend longevity in a variety of organisms. For example, deletion of TOR1 
extends lifespan in yeast and rapamycin treatment extends lifespan in rodents (Harrison et al., 
2009). Genetic ablation of the downstream target of TOR, Sch9 in yeast and S6K in rodents, can 
also extend longevity (Selman et al., 2009, Fabrizio et al., 2001). In flies, 4EBP is upregulated 
upon DR and may contribute to translational derepression of nuclear-encoded mitochondrial 
electron transport chain components (Zid et al., 2009). Because DR can reduce TOR signaling to 
downstream targets including S6K and 4EBP, this could be a primary mechanism underlying its 
longevity effects (Figure 1.2).  
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Figure 1.2. Model for amino acid sensing pathways in DR benefits.  Modulation of activity of 
GCN2 or TOR pathways by dietary or pharmacological interventions can lead to benefits. Not all 
interventions necessarily lead to all benefits. Dashed lines indicate indirect or hypothesized 
effects; solid lines indicate known or direct effects. In some cases, yeast/mammalian gene names 
are both indicated, respectively.  
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Aside from the essential role of GCN2 in surgical stress resistance by short-term tryptophan 
deficiency (Peng et al., 2012), there is little in the DR or longevity literature on the potential role 
of this amino acid deprivation sensing kinase. This is perhaps surprising in light of established 
models of longevity extension involving amino acid restriction in rodents or amino acid 
imbalance in flies, combined with data suggesting the ability of GCN2 activation to inhibit 
mTOR activity upon amino acid deprivation. It may be that redundancy in mammalian eIF2! 
kinases, as well as multiple additional routes of mTOR inhibition, may abrogate the specific 
genetic requirement for GCN2 in a number of settings. Nonetheless, activation of GCN2 via 
dietary or antimetabolite means would seem a productive area of future research, including the 
role of translational control in downstream benefits (Figure 1.2). 
In yeast, GCN4 stabilization has been implicated in both chronological and replicative longevity 
extension (Steffen et al., 2008, Alvers et al., 2009).  In the replicative longevity model, lifespan 
is extended by knocking out any of a number of 60S ribosomal subunits or inhibiting 60S subunit 
biogenesis with small molecules (Steffen et al., 2008).  By reducing the 60S subunit, 
translational initiation becomes inefficient, mimicking the effects of GCN2 activation and eIF2! 
phosphorylation on downstream GCN4 stabilization. Thus, transcriptional reprogramming by 
GCN4 may play a role in longevity extension, whether or not it is stabilized upon GCN2 
activation or by some other process. 
In addition to translational control, GCN2 and TOR control a number of other processes that 
could also contribute to reported benefits of DR, including autophagy, energy metabolism, 
immune function and food intake. Autophagy is an adaptive process that provides biological 
material (amino acids, lipids) to sustain anabolic processes (Yang and Klionsky, 2010) under 
conditions of nutrient depletion, including DR. mTORC1 negatively regulates autophagy by 
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suppressing the ULK1 complex via phosphorylation (Zoncu et al., 2011b). In yeast, GCN2 and 
GCN4 are required for the induction of autophagy upon amino acid depletion (Ecker et al., 2010, 
Talloczy et al., 2002). DR also results in changes in energy metabolism regulated at least in part 
by mTORC1, including fatty acid synthesis, glycolysis and the pentose phosphate pathway via 
the transcription factors Hif1! and SREBP (Duvel et al., 2010, Yecies et al., 2011). GCN2 can 
also impact fat metabolism. In addition to activation of amino acid biosynthesis and transport, 
GCN2 is required for suppression of fatty acid synthesis in the liver upon leucine deprivation 
(Guo and Cavener, 2007). Although this particular function of GCN2 is independent of ATF4, 
the broader role of this transcription factor in GCN2-dependent effects remains to be explored. 
Immune function, including auto-immunity, can have a major impact on lifespan and aging-
related disease in multicellular organisms. Activation of GCN2 upon local tryptophan depletion 
by the tryptophan catabolizing enzyme IDO is one strategy to reduce T cell proliferation and 
induce tolerance toward such unintended targets as apoptotic cells in the spleen (Munn et al., 
2005) or the allogeneic fetus. Activation of the amino acid starvation response by the small 
molecule halofuginone, a prolyl-tRNA synthase inhibitor (Keller et al., 2012), prevents 
differentiation of inflammatory TH17 cells (Sundrud et al., 2009). mTOR inhibition by 
rapamycin can also induce tolerance by suppressing T cell proliferation, but is paradoxically 
proinflammatory in the context of innate immune activation (Weichhart et al., 2008, Fielhaber et 
al., 2012). 
Finally, GCN2 and mTOR can both participate through different mechanisms in behavioral 
control of food intake. Central administration of leucine activates hypothalamic mTOR and 
reduces food intake (Cota et al., 2006). Diets lacking one or more essential amino acids cause an 
aversion to food intake centered in a different brain region, the anterior piriform cortex (APC) 
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(Gietzen et al., 2007). GCN2 is activated rapidly in the APC upon dietary amino acid deprivation 
or stereotactic injection of amino acid alcohol derivatives that compete for tRNA synthetases, 
resulting in uncharged tRNA accumulation (Hao et al., 2005, Ross, 1961). Nonetheless, mice 
lacking GCN2 still display aversion to incomplete diets over the period of days to weeks 
(Anthony et al., 2004, Guo and Cavener, 2007, Peng et al., 2012), suggesting a redundant 
mechanism of amino acid deprivation sensing. Future studies will be required to elucidate the 
role of food aversion, if any, to the benefits of amino acid restriction. 
Pharmacological activators of amino acid starvation response as DR mimetics?  
DR mimetics can be loosely defined as interventions that mimic some beneficial aspect of DR, 
for example lifespan extension, maintenance of metabolic fitness upon challenge with a high fat 
diet, or increased stress resistance. Metformin and rapamycin both extend lifespan in rodents, 
and are thus considered DR mimetics (Harrison et al., 2009, Anisimov et al., 2005) (Figure 1.2). 
Halofuginone is a prolyl-tRNA synthetase inhibitor that activates the amino acid starvation 
response by mimicking proline deprivation. Like short-term essential amino acid deprivation, 
halofuginone can increase resistance to renal ischemia reperfusion injury in a GCN2-dependent 
manner (Peng et al., 2012). This serves as proof of principle that compounds that activate GCN2 
and stimulate the amino acid starvation response can have benefits similar to dietary 
protein/amino acid restriction. Nonetheless, this antimetabolite and others in its class are toxic 
due to on-target effects of tRNA synthetase inhibition. More desirable would be a DR mimetic 
that would activate the GCN2 kinase directly without inhibiting tRNA charging, or selectively 
inhibit amino acid sensing through the mTOR pathway. Our understanding of the mechanisms 
underlying amino acid sensing will likely improve the chances of identifying such a compound 
with potential beneficial uses in humans. 
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SUMMARY 
Protein restriction (PR) is important for the benefits of dietary restriction on longevity and stress 
resistance, but relevant nutrient sensors and downstream effectors in mammals remain poorly 
defined. We used PR-mediated protection from hepatic ischemia reperfusion injury to probe 
genetic requirements for evolutionarily conserved nutrient sensors GCN2 and mTORC1 in stress 
resistance. One week of PR reduced free amino acids and circulating growth factors, activating 
GCN2 and mTORC1 repressor TSC complex. However, while GCN2 was dispensable for PR-
induced protection, hepatic TSC1 was required. PR improved hepatic insulin sensitivity in a 
TSC1-dependent manner prior to ischemia, facilitating increased pro-survival signaling and 
reduced apoptosis after reperfusion. These benefits were partially abrogated by pharmacological 
PI3K inhibition or genetic deletion of the insulin receptor in hepatocytes. In conclusion, 
improved insulin sensitivity upon short-term PR required TSC1, facilitated increased pro-
survival signaling after injury, and contributed partially to PR-mediated resistance to clinically 
relevant ischemia reperfusion injury. 
 
BACKGROUND 
Dietary restriction (DR) is loosely defined as reduced food intake without malnutrition and refers 
to a variety of dietary interventions including both simple reduction of calorie intake and 
restriction of specific macronutrients. Beneficial health effects of DR were reported in the 1930s, 
when DR was shown to extend longevity in rats (McCay et al., 1935). DR has since been shown 
to increase maximal and average lifespan in multiple species including yeasts, worms, flies, fish 
and rodents (Fontana et al., 2010). In addition to the metabolic and cardiovascular improvements 
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seen in mammals, DR also improves resistance to a variety of stressors such as chemotherapeutic 
agents (Raffaghello et al., 2008, Cheng et al., 2014) and ischemia reperfusion injury (IRI) to the 
kidney, liver, heart and the brain (Mitchell et al., 2010, Varendi et al., 2014, Robertson and 
Mitchell, 2013). 
Restriction of calories from any macronutrient source - proteins, lipids or carbohydrates – can 
result in DR benefits, including lifespan extension. Therefore, the term DR has been used 
interchangeably with caloric restriction (CR). However, accumulating evidence suggests that 
specific macronutrients – namely amino acids – play a role in DR benefits beyond their caloric 
value (Piper et al., 2011, Levine et al., 2014, Solon-Biet et al., 2014). Numerous studies in 
rodents have shown that total protein restriction and restriction of individual essential amino 
acids (EAA) tryptophan and methionine increase longevity in rats and mice (Gallinetti et al., 
2013). In addition to longevity extension, dietary protein or individual EAA restriction can both 
mediate other DR-like effects, including improved insulin sensitivity upon leucine restriction 
(Xiao et al., 2011) and protection against IRI in liver and kidney upon tryptophan restriction 
(Peng et al., 2012). While EAA, protein, and total calorie restriction induce shared phenotypes, 
including decreased adiposity, decreased circulating growth hormones (insulin, IGF-1) and 
improved insulin sensitivity, whether or not these are common effectors of associated benefits 
remains to be tested. 
Two evolutionarily conserved signal transduction pathways sense amino acids: general control 
nonderepressible 2 (GCN2) and mechanistic target of rapamycin complex 1 (mTORC1). GCN2 
senses the absence of any individual amino acid via binding to uncharged cognate tRNAs and 
activates the amino acid starvation response by phosphorylating Ser51 of the translation 
initiation factor eIF2!. This results in global translational suppression together with translational 
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derepression of specific mRNAs such as Atf4 (Gallinetti et al., 2013). GCN2 is required for 
mediating the beneficial effects of short-term individual EAA deficiency against hepatic and 
renal IRI (Peng et al., 2012).  
mTORC1 is a complex of the serine/threonine kinase mTOR, Raptor, and mLst8 as core 
essential components and integrates various growth stimulating signals including amino acids, 
energy and growth factors (Dibble and Manning, 2013). Intracellular amino acids, and in 
particular the branched chain amino acid leucine, are sensed by mTORC1 via an upstream 
mechanism involving the Rag GTPases (Sancak et al., 2008) and a regulatory complex referred 
to as the Ragulator (Efeyan et al., 2012). Leucine sufficiency allows recruitment of mTORC1 to 
the lysosomal surface via the Ragulator. There, mTORC1 can be activated by the small GTPase 
Rheb, which in turn is negatively regulated by the GTPase-activating protein (GAP) tuberous 
sclerosis complex 2 (TSC2), which functions in a complex with TSC1 and TBC1D7 (the TSC 
complex) (Huang and Manning, 2008, Dibble et al., 2012). The TSC complex is a critical 
negative regulator of mTORC1 that integrates signals from energy levels and growth and 
endocrine factors, such as insulin. Although growth factor-based TSC-dependent inhibition of 
mTORC1 is experimentally separable from amino acid-based Ragulator-dependent inhibition in 
vitro (Menon et al., 2014), whether the TSC complex plays a role in controlling mTORC1 in 
response to dietary protein restriction in vivo remains unknown. 
Inhibition of mTORC1 (Harrison et al., 2009, Miller et al., 2011, Miller et al., 2013, Lamming et 
al., 2012, Wu et al., 2013) or its direct target S6K (Selman et al., 2009), has been implicated in 
DR-like benefits including lifespan and healthspan extension; however, the requirement for 
mTORC1 inhibition in DR-mediated stress resistance, and the potential role of the TSC complex, 
remain unknown. Although S. cerevisiae and C. elegans lack TSC homologs, overexpression of 
 48 
TSC1 and TSC2 in Drosophila extends longevity, consistent with a beneficial role of reduced 
mTORC1 signaling (Kapahi et al., 2004). A protective role of the TSC complex via autophagy 
induction in an mTORC1-dependent manner has also been suggested in a recent study of 
neuroprotection against ischemia (Papadakis et al., 2013).  
Ischemia reperfusion injury (IRI) is a multifactorial acute stress involving occlusion of blood 
flow to an organ or tissue for a certain period of time (ischemia) and subsequent return of blood 
flow (reperfusion). During the ischemic period, cells are deprived of oxygen and nutrients, 
resulting in ATP depletion, loss of membrane potential and accumulation of toxic byproducts. 
Subsequent reperfusion introduces additional damage via the actions of inflammatory mediators, 
leading to both apoptotic and necrotic cell death (Jaeschke, 2003). IRI underlies a variety of 
clinically significant events ranging from heart attack and stroke to surgical interventions 
requiring temporary restriction of blood flow. Here we investigated the contributions of the 
TSC/mTORC1 and GCN2 pathways in sensing dietary protein restriction and mediating 
protective effects against hepatic IRI using mice deficient in GCN2 or lacking hepatocyte-
specific expression of the essential TSC complex component TSC1. 
 
RESULTS 
DIETARY PROTEIN RESTRICTION MEDIATES STRESS RESISTANCE 
INDEPENDENT OF GCN2 
To determine an optimal 1-week dietary preconditioning regimen against hepatic IRI, we 
focused on restricting dietary protein intake either by restricting intake of a complete diet (35% 
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or 55% restriction) or by removing protein from the diet (protein restriction, PR) (Figure 2.1A). 
Food restriction was calculated on the basis of food intake of ad libitum-fed mice on a complete 
diet and normalized by animal weight (Figure 2.1B). Because mice on a protein free diet often 
display temporary aversion to food intake (Peng et al., 2012), the PR diet was restricted by 35% 
to normalize daily food intake between experiments. Hepatic IRI was induced by clamping the 
hepatic artery, portal vein and the bile duct for 30-35 minutes, followed by reperfusion for up to 
24 hrs. Liver damage was assessed by measuring the release of cellular enzymes into the 
bloodstream. Maximal protection correlated with the least protein intake rather than restriction of 
calories (Figure 2.1C). Therefore, we used the protein restriction (PR) regimen to further 
characterize the responsible signaling pathways and downstream effector mechanisms. 
Recently, we showed that GCN2 is required for mediating the protective effects of single EAA 
restricted diets against renal and hepatic IRI (Peng et al., 2012). To test whether GCN2 is 
required for mediating the benefits of total protein restriction against hepatic IRI, we 
preconditioned Gcn2 knockout (GCN2KO) mice on complete, tryptophan restricted (Trp-) or PR 
diets for one wk. Damage assessment 3 hours after reperfusion revealed no significant difference 
between complete and Trp- diets; however, GCN2KO mice preconditioned on the PR regimen 
were significantly protected (Figure 2.1D, 2.1E). Thus, GCN2 was dispensable for 
preconditioning by PR, indicating the likely involvement of another amino acid sensing pathway.  
The mTORC1 pathway can also sense amino acids, and is inhibited in the absence of specific 
amino acids, including leucine. We thus tested whether the mTORC1 pathway is still responsive 
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Figure 2.1 Dietary protein restriction mediates stress resistance independent of GCN2.  
(A) Compositions of the experimental diets, represented as kcal%. Protein was replaced on a per 
weight basis with isocaloric sucrose in the protein-free diet. 
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Figure 2.1 (Continued) 
(B) Food intake and body weight curves of male mice preconditioned on the indicated diets for 1 
week prior to hepatic IRI; n = 5 mice/group. Complete: ad libitum access to complete diet; 35% 
DR: 65% of ad libitum food allowance on complete diet; 55% DR: 45% of ad libitum food 
allowance on complete diet, PR: 65% of ad libitum food allowance on protein-free diet. Hepatic 
IRI was induced on day 0. 
(C) Serum LDH, ALT and AST activity of mice shown in (B) before ischemia (0 hr) and 3 hours 
after reperfusion. Asterisks indicate the significance of the difference vs. the Complete group by 
1-way ANOVA with Dunnett’s test for multiple comparisons, multiplicity adjusted p-values; *p 
< 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001. 
(D) Serum ALT activity before ischemia (0 hr) and 3 hours after reperfusion in female GCN2KO 
mice preconditioned on the indicated diets for 1 week prior to hepatic IRI; n = 4-5 mice/group. 
Complete: ad libitum access to complete diet; PR: 65% of ad libitum food allowance on protein-
free diet; Trp-: 65% of ad libitum food allowance on tryptophan-free diet. Asterisk indicates the 
significance of the difference vs. the Complete group by student’s t-test; *p < 0.05. 
(E) Food intake and body weight curves for the mice in (D). Hepatic IRI was induced on day 0. 
(F) Immunoblots of markers of mTORC1 signaling in extracts from primary dermal fibroblasts 
or hepatocytes isolated from WT or GCN2KO mice and treated with the indicated media in the 
presence of 10% dialyzed FBS (2 hours for MDFs, 3 hours for hepatocytes). Complete: complete 
DMEM; AA-free: amino acid-free DMEM; MEM: minimum essential medium amino acid mix;  
 
 52 
Figure 2.1 (Continued) 
AA: all amino acids added back to 1x DMEM concentration; Rapamycin: 20 nM. Data in all 
panels are shown as means ± SD.  
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to amino acid deprivation in vitro in two different GCN2KO cell types, primary dermal 
fibroblasts and primary hepatocytes (Figure 2.1F). Phosphorylation of downstream targets of 
mTORC1, including S6K1, its target S6, and 4E-BP1 (as scored by mobility shifting), were 
proportionately reduced in both wild type (WT) and GCN2KO cells upon total amino acid 
withdrawal. We conclude that the mTORC1 pathway can sense amino acid restriction 
independent of GCN2, and could thus be a potential mediator of PR preconditioning effects. 
THE TSC COMPLEX IS REQUIRED FOR INHIBITION OF MTORC1 UPON PR IN 
VIVO 
We next determined the effects of PR on hepatic mTORC1 activity in vivo using both WT and 
liver-specific Tsc1 knockout (LTsc1KO) mice, a model of constitutive mTORC1 activation in 
the liver (Yecies et al., 2011, Menon et al., 2012, Sengupta et al., 2010, Kenerson et al., 2011). 
WT and LTsc1KO mice were fed a complete or PR diet for one week (Figure 2.2A). Both 
genotypes lost approximately 20% of their body weight (Figure 2.2B, 2.2C), including loss of 
adipose mass (Figure 2.2D). In WT mice on PR, livers tended to weigh less, and were thus 
maintained as a percentage of body weight; in LTsc1KO mice on PR, liver weights did not 
decrease, resulting in disproportionately larger livers (Figure 2.2B), consistent with failure of 
LTsc1KO mice to reduce mTORC1 signaling upon PR. 
To confirm differential regulation of hepatic mTORC1 signaling upon PR, we looked in liver 
extracts at downstream mTORC1 targets and related nutrient/energy sensing pathways. PR 
increased phosphorylation of eIF2! (Figure 2.2E, 2.2F) and expression of downstream markers 
of the GCN2-dependent amino acid starvation response, including the ATF4 target gene Asns 
(Figure 2.2G). Higher baseline eIF2! phosphorylation in LTsc1KOs could be due in part to 
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Figure 2.2 The TSC complex is required for inhibition of mTORC1 upon PR in vivo. 
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Figure 2.2 (Continued) 
(A,) Daily food intake of WT and LTsc1KO mice on the indicated diet measured at the same 
time of the day. Data were pooled from 3 separate experiments; n = 4-5 mice per group for each 
experiment. 
(B) Body and liver weights of the indicated genotype after 1 week on the indicated diet; n = 4-5 
mice/group. Body weight on the last day of treatment is represented as percentage of initial 
weight (top). Liver weights on the last day of treatment are represented as absolute values 
(middle) and percentages of body weight (bottom). Asterisks indicate the significance of the 
difference between diets within genotype by student’s t-test; **p < 0.01, ***p < 0.00001. 
(C) Body weight measurements of WT and LTsc1KO mice on the indicated diet measured at the 
same time of the day. Data were pooled from 3 separate experiments; n = 4-5 mice per group for 
each experiment. 
(D) Body fat as measured with Echo-MRI prior to and one week after preconditioning on the 
indicated diet, expressed as the % change in body fat; n = 5 mice per group. Statistical 
significance was measured by student’s t-test between Complete and PR groups within each 
genotype; ***p < 0.0005. 
(E) Immunoblots of markers of mTORC1, GCN2 and AMPK activation in liver extracts from 
WT and LTsc1KO male mice after 1 week on the indicated diet. 
(F) Quantification of the blots shown in Figure 2B. Statistical significance was measured by 
student’s t-test between Complete and PR groups within each genotype; *p < 0.05, **p < 0.01, 
***p < 0.0005. 
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Figure 2.2 (Continued) 
 (G) mRNA levels of ATF4 target genes Asns and 4ebp1 in livers of WT and LTsc1KO mice on 
the indicated diet; n = 4-5 mice per group. Statistical significance was measured by student’s t-
test between Complete and PR groups within each genotype; *p < 0.05, ***p < 0.001. Data in all 
panels are shown as means ± SD. 
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higher endoplasmic reticulum (ER) stress (Menon et al., 2012). In WT livers, we observed a 
reduction in S6K and S6 phosphorylation upon PR (Figure 2.2E, 2.2F). Total levels of 4EBP1, 
which is also an ATF4 target gene (Yamaguchi et al., 2008), increased in both genotypes upon 
PR; therefore changes in phosphorylation of this mTORC1 target are difficult to interpret (Figure 
2.2E, 2.2G). mTORC1 signaling in Tsc1KO livers was greatly increased relative to WT, and 
unaffected by PR, if not slightly elevated (Figure 2.2E, 2.2F). Interestingly, even though AMPK 
phosphorylation in some WT livers was increased upon PR, the observed changes were not 
statistically significant likely due to biological variability; there was no evidence of increased 
AMPK phosphorylation upon PR in LTsc1KO livers (Figure 2.2E, 2.2F). 
DIFFERENTIAL REDUCTION OF ESSENTIAL AMINO ACIDS AND GROWTH 
FACTORS IN VIVO UPON PR 
To test the role of amino acid deficiency on cell-autonomous mTORC1 signaling, primary WT 
or TSC1KO hepatocytes were cultured for 2 hours in media lacking amino acids. In WT 
hepatocytes, this led to the reduction of S6K and S6 phosphorylation below the level of detection 
(Figure 2.3A). Although Tsc1KO hepatocytes had much higher baseline levels of p-S6K, they 
also responded to amino acid deprivation in vitro, confirming the ability of amino acid 
deprivation to reduce mTORC1 activity independent of the TSC complex.  
If amino acid deficiency could at least partially abrogate mTORC1 signaling in Tsc1KO 
hepatocytes in vitro, why did PR fail to reduce mTORC1 signaling at all in LTsc1KO livers in 
vivo? To answer this, we first measured free amino acids in the serum and in liver. One week of 
PR reduced most free EAA, including leucine, in the serum and liver in both WT and LTsc1KO 
animals, but only by approximately 20-30% on average (Figure 2.3B, 2.3C); non-essential amino  
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Figure 2.3 Differential reduction of essential amino acids and growth factors in vivo upon 
PR. 
(A) Immunoblots of mTORC1 targets from extracts of primary hepatocytes isolated from WT or 
LTsc1KO mice and starved of amino acids in the presence of 10% dialyzed serum (dFBS) for 2 
hours prior to lysis, coincident with 1x MEM addition +/-  20nM rapamycin (Rap) as indicated.  
(B, C) Free EAA levels in serum (B) and liver (C) of WT or LTsc1KO mice on the indicated diet 
expressed as fold change relative to the WT complete diet group; n = 4-5 mice/group.  
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Figure 2.3 (Continued) 
Asterisks/number signs indicate the significance of the difference between diets within genotype 
by student’s t-test; */#p < 0.05.  
(D, E) Free NEAA levels in serum (D) and liver (E) of WT or LTsc1KO mice on the indicated 
diet expressed as fold change relative to the WT complete diet group; n = 4-5 mice per group. 
Asterisks/number signs indicate the significance of the difference between diets in WT and 
LTsc1KO groups, respectively, by student’s t-test; */#p < 0.05. 
(F-H) Blood glucose (F), serum insulin (G) and IGF-1 (H) levels of WT or LTsc1KO mice on 
the indicated diet; n = 4-5 mice/group for each experiment, with data pooled from 3 separate 
experiments (F). Asterisks indicate the significance of the difference between diets within 
genotype by student’s t-test; *p < 0.05, **p < 0.01, ****p < 0.0000001. Data in all panels are 
shown as means ± SD. 
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acids were not uniformly affected (Figure 2.3D, 2.3E). Blood glucose was similarly reduced 
upon PR in both genotypes by 20-40% (Figure 2.3F). However, circulating levels of growth 
factors were reduced by more than 5 fold for insulin and 3 fold for IGF-1 upon PR (Figure 2.3G, 
2.3H). Taken together, these data suggest that buffering of free amino acid concentrations in vivo 
upon PR prevents Rag/Ragulator-based mTORC1 inhibition in LTsc1KO livers, and confirms 
LTsc1KO mice as a suitable model of constitutive hepatic mTORC1 activation, despite intact 
systemic changes in upstream mTORC1 regulators in response to diet. 
THE TSC COMPLEX IS REQUIRED FOR BENEFITS OF PR AGAINST ACUTE 
HEPATIC STRESS 
To determine the requirement for the TSC complex and suppression of mTORC1 on PR-
mediated stress resistance, we tested the response of female WT and LTsc1KO mice to hepatic 
IRI. We observed a significant reduction of serum damage markers LDH, ALT and AST in WT 
animals on PR, but this benefit was lost in LTsc1KOs (Figure 2.4A, 2.4B). As a control, changes 
in the serum levels of these enzymes were not due to differential enzyme activity levels in 
undamaged livers (Figure 2.4C). H&E-stained sections from formalin-fixed livers harvested 24 
hours after reperfusion from all 4 groups were analyzed for necrotic cell death, which appeared 
as lightly stained areas with loss of hepatocyte morphology (Figure 2.4D). Blind scoring in serial 
sections confirmed the reduction of necrotic tissue in WT livers upon PR, and the loss of this 
benefit in LTsc1KOs (Figure 2.4E). The same relative differences in hemorrhagic necrosis could 
also be observed at the macroscopic level in whole livers (Figure 2.4D). Body temperatures of 
LTsc1KO and WT mice upon PR were similarly reduced (Figure 2.4F), ruling out the possibility 
of differential temperatures in protection by PR in WT mice. Finally, PR-mediated protection 
from hepatic IRI was partially abrogated in LTsc1KO males (Figure 2.4G). Taken together, these  
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Figure 2.4 The TSC complex is required for benefits of PR against acute hepatic stress. 
(A) Serum LDH, ALT and AST activity before ischemia (0 hr) and 3 or 24 hours after 
reperfusion in female WT or LTsc1KO mice preconditioned on the indicated diets for 1 week 
prior to hepatic IRI; n = 4-6 mice/group for each experiment, with data pooled from 4 separate 
experiments for 0 and 3 hours and a single experiment for 24 hrs. Asterisks indicate the 
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Figure 2.4 (Continued) 
significance of the difference between diets within genotype by student’s t-test; **p < 0.001, 
***p < 0.00001, ****p < 1 x 10-8. 
(B) Liver damage marker analysis using Piccolo Liver Plus Panel discs with serum collected 
from the indicated groups 24 hours post-reperfusion. Data is represented as % of complete diet 
fed group for each genotype; n = 2-5 mice per group; **p < 0.01, ***p < 0.005. 
(C) Total liver enzyme analysis from liver extracts of mice from the indicated groups. Frozen 
livers were lysed in NP-40 lysis buffer, and the activity of the LDH, ALT and AST enzymes 
were measured in extracts with kinetic assays. Values were normalized to protein content of each 
sample; n = 4-5 mice per group. 
(D) Representative images of H&E stained sections from non-ischemic (left) or ischemic livers 
24 hours after reperfusion (right) from WT or LTsc1KO mice preconditioned on the indicated 
diets for 1 week prior to hepatic IRI. Lightly stained areas with loss of hepatocyte morphology 
indicate necrotic tissue. Right: representative images of whole livers 24 hours after IRI and fixed 
with formalin, with areas of hemorrhagic necrosis appearing as dark red. Scale bar: 400 µm. 
(E) Quantification of hepatic cell death expressed as percentages of necrotic region/field in 3-5 
mice/group, 3 sections/sample; Asterisks indicate the significance of the difference between diets 
within genotype by student’s t-test; **p < 0.01, ns: not significant. 
(F) Core body temperature of mice measured with a rectal probe immediately before induction of 
ischemia. Results were pooled from 4 separate experiments with n = 4-5 mice per group per 
experiment; **p < 0.005, ***p < 0.001 by student’s t test between diets within genotype. 
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Figure 2.4 (Continued) 
 (G) Serum levels of LDH, ALT and AST measured before ischemia (0 hr) and 3 hours after 
reperfusion in male WT or LTsc1KO mice 12-15 weeks of age preconditioned on the indicated 
diets for 1 week prior to hepatic IRI; pooled results from 3 separate experiments with n = 4-6 
mice per group per experiment. Student’s t-tests were performed to assess statistically significant 
differences between WT-PR and LTsc1KO-PR groups; *p < 0.05, **p < 0.01, ***p < 0.0005. 
Data in all panels are shown as means ± SD. 
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results indicate the requirement for the TSC complex in the protective effect of PR against 
hepatic IRI.  
In order to investigate potential differences in protective mechanisms by total protein (PR) and 
tryptophan restriction (Trp-), we tested the response of female LTsc1KO mice to one week of 
preconditioning on a Trp- diet. Interestingly, we observed that LTsc1KO mice were still 
responsive to Trp- diet in terms of protection from hepatic IRI (Figure 2.5). Taken together, these 
data indicate that beneficial effects of total protein restriction and tryptophan restriction have 
different genetic requirements, suggesting a parallel rather than epistatic relationship between 
TSC/mTORC1 and GCN2 amino acid sensing pathways in protection from hepatic IRI. 
Rapamycin is a partial mTORC1 inhibitor that increases longevity in mice (Harrison et al., 2009, 
Miller et al., 2011, Miller et al., 2013). We tested the ability of rapamycin to induce benefits 
against hepatic IRI similar to PR. To this end, WT mice were injected with rapamycin at varying 
concentrations for up to one week in the absence of any dietary intervention. Despite reducing 
mTORC1 activity, none of the rapamycin regimens tested were beneficial against hepatic IRI 
(Figure 2.6A, 2.6B). Interestingly, we observed that thrice weekly rapamycin treatment partially 
abrogated PR benefits and reduced mTORC2 activity as assessed by NDRG1 phosphorylation 
(Figure 2.6B, 2.6C), suggesting that the effects of rapamycin on mTORC2 might be detrimental 
in the context of hepatic IRI. 
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Figure 2.5 The TSC complex is not required for benefits of Tryptophan restriction. 
Serum levels of LDH, ALT and AST measured before (0 hr) or 3 hours after reperfusion in WT 
and LTsc1KO mice preconditioned on the indicated diets for 1 week prior to hepatic IR. Data 
were pooled from 3 separate experiments with n = 14, 15, 14, 13 mice total for WT-Complete, 
WT-Trp-, LTsc1KO-Complete and LTsc1KO-Trp- groups, respectively. Complete: 65% of ad 
libitum food intake on a complete diet; Trp-: 65% of ad libitum food intake on a tryptophan-free 
diet. To assess statistical significance, student’s t-tests were performed to compare Complete and 
Trp- groups within each genotype. *p < 0.05, **p < 0.01. Data in all panels are shown as means 
± SD. 
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Figure 2.6 Rapamycin treatment partially abrogates PR benefits 
(A) Serum levels of LDH, ALT and AST measured before ischemia (left) and 3 hours after 
reperfusion (right) in WT female C57Bl/6J mice fed a control diet ad libitum and subject to the 
indicated rapamycin or vehicle treatment by intraperitoneal injection. 3 days: daily injection of 
rapamycin for 3 consecutive days before IRI; 1 week: 3 injections of rapamycin over a week 
before IRI; 1 hour: a single injection with rapamycin 1 hour prior to IRI. Pooled results from 5 
separate experiments are shown, with n = 25 for the vehicle group (V), n = 5 for 3 day treatment 
groups, and n = 10 for 1 week and 1 hour treatment groups. All groups were compared to the 
vehicle treated group for statistical analysis using a 1-way ANOVA with Dunnett’s test for 
multiple comparisons. Asterisk indicates multiplicity adjusted p-value below 0.05. 
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Figure 2.6 (Continued) 
 (B) Immunoblots of mTORC1 targets in liver extracts of the indicated groups of WT mice fed a 
complete diet ad libitum or preconditioned with PR and treated with either vehicle or rapamycin 
(5 mg/kg i.p. 3 times/week) for 1 week. Mice were fasted overnight prior to harvest and 
stimulated with insulin (0.25 U/kg i.p.) 10 minutes before sacrifice. 
(C) Serum levels of LDH, ALT and AST measured before (0 hr), 3 hours and 24 hours post-
reperfusion in mice preconditioned with the indicated diets, and treated with either vehicle or 
rapamycin (5 mg/kg i.p. 3 times/week) for 1 week prior to hepatic IRI. Results were pooled from 
2 separate experiments with n = 4-5 mice per group in each experiment. Complete-V control 
group data was also used in panel (B). Asterisks  indicate statistically significant differences 
between Complete-V and PR-V groups according to a student’s t-test, *p < 0.05, **p < 0.005, 
***p < 0.0005, #p < 0.05, ##p < 0.005. Data in all panels are shown as means ± SD. 
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THE TSC COMPLEX IS REQUIRED FOR IMPROVED HEPATIC INSULIN 
SENSITIVITY UPON PR 
By what downstream mechanism does TSC complex activation and mTORC1 repression 
improve stress resistance? Improved insulin sensitivity upon DR is associated with a wide range 
of health benefits including stress resistance and extended longevity (Fontana et al., 2010). We 
thus tested the ability of PR to increase hepatic insulin sensitivity in a TSC1-dependent manner. 
One week of PR reduced fasting insulin, resulting in a significantly reduced HOMA-IR (Figure 
2.7A-C) consistent with improved insulin sensitivity. To directly test the effects of PR on hepatic 
insulin sensitivity, we measured the levels of Akt phosphorylation in extracts from WT livers 
following stimulation with insulin. WT mice on PR for one week had higher levels of pAkt-S473 
and pAkt-Thr308 compared to controls (Figure 2.7D). Levels of Akt phosphorylation in Tsc1KO 
livers upon insulin stimulation were lower than in WT livers, consistent with previous findings 
(Yecies et al., 2011), but did not improve upon PR in Tsc1KOs as they did in WT controls 
(Figure 2.7E). Together, these findings show that the TSC complex is required for improvement 
in hepatic insulin sensitivity upon PR. 
In the context of DR, improved insulin sensitivity is associated with reduced anabolic hormone 
levels (as observed here, Figure 2.3G, 2.3H) and, consequently, reduced insulin/IGF-1 signaling. 
Reduced insulin/IGF-1 signaling is an evolutionarily conserved mechanism regulating longevity 
and stress resistance in part by controlling cytoprotective gene expression (Fontana et al., 2010). 
To evaluate a potential impact of increased cytoprotective gene expression, we measured 
expression of genes controlled by both FoxO and NRF2 transcription factors. However, no 
significant increases in the levels of these genes were observed upon PR, nor did TSC1 ablation 
have consistent effects (Figure 2.7F, 2.7G). 
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Figure 2.7 The TSC complex is required for improved hepatic insulin sensitivity upon PR. 
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Figure 2.7 (Continued) 
(A-C) Glucose homeostasis in WT female C57Bl/6J mice at 11-13 weeks of age (n=12/group) on 
the indicated diet for up to 10 days. (A) Blood glucose measured after 6 hours (day 10) or 13 
hours (day 7) of fasting. (B) Serum insulin levels measured after 13 hours of fasting on day 7. 
(C) HOMA-IR index was calculated as: [fasting glucose (mg/dl) * fasting insulin (µU/ml)]/405. 
Asterisks  indicate statistically significant differences between diet groups according to a 
student’s t-test; **p < 0.01, ns: not significant. 
(D) Hepatic insulin sensitivity as determined by immunoblotting for markers of Akt pathway 
activation in liver extracts from mice fasted overnight and then stimulated with insulin (0.25 
U/kg i.p.) 10 minutes prior to harvest.  
(E) Insulin sensitivity as determined by immunoblotting for markers of Akt pathway activation 
in liver extracts from mice fasted for 6 hours and then stimulated with 0.5 U/kg insulin by portal 
vein injection 3 min before harvest. 
(F, G) Gene expression analysis of FOXO (F) or NRF2 (G) targets by qRT-PCR from livers of 
WT and LTsc1KO mice (n = 4-5 mice per group) on the indicated diet. For each gene, data are 
represented as fold changes with respect to the WT-AL group. Asterisks  indicate statistically 
significant differences between diet groups within genotype according to a student’s t-test; *p < 
0.05. 
(H) Hepatic insulin signaling as determined by immunoblotting for markers of Akt and 
mTORC1 pathways in liver extracts prepared from WT mice fed ad libitum and harvested either 
without surgery (NI: non-ischemic) or at various time points during surgery. Isc-35 min: at the  
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Figure 2.7 (Continued) 
end of the 35 minutes ischemic period; 5, 15 and 30 minutes: Time after reperfusion. Each well 
represents an individual animal. 
(I) Hepatic insulin signaling as determined by immunoblotting for markers of Akt activation in 
extracts of livers from WT mice on the indicated diet for 1 week. Livers were harvested either 
without surgeries (NI: non-ischemic), at the end of the ischemic period (35 min ischemia) or 30 
minutes into the reperfusion period. 
(J) Akt activation status as determined by immunoblotting of liver extracts 3 hours after 
reperfusion from mice preconditioned for 1 week on the indicated diet prior to induction of 
hepatic IRI. 
(K) Serum insulin levels from tail blood of WT mice preconditioned for 1 wk on the indicated 
diet taken prior to ischemia (0 hr), at the end of the ischemic period (30 min I, n=3-4), 30 min 
after reperfusion period (30 min R, n=3) or 3 hrs after reperfusion (3 hrs R, n=11-12). Asterisk 
indicates the significance of the indicated comparison according to a Kruskal-Wallis test 
followed by Dunn’s multiple comparisons test; *p < 0.05; ns: not significant. 
(L) Blood glucose levels of mice on the indicated diets for 1 wk before hepatic IRI, measured 
before (0hr) and 3 hrs after reperfusion; n = 8-10 mice/group. Asterisks indicate the significance 
of the difference between 0 and 3 hr values by student’s t test within diet group; **p < 0.001, 
***p < 0.0001. Data in all panels are shown as means ± SD.  
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In contrast to the potential benefits of reduced insulin/IGF-1 signaling named above, increased 
growth factor signaling after injury can trigger anti-apoptotic survival signaling and improve 
functional recovery (Fuglesteg et al., 2009, Jonassen et al., 2001, Liu et al., 2007). In order to 
address the potential protective effects of increased insulin/IGF-1 signaling after injury in the 
context of protection from hepatic IRI, we determined the status of insulin/Akt signaling at 
various time points during ischemia and after reperfusion. Akt signaling was dramatically 
reduced during ischemia and returned rapidly within 15 minutes of reperfusion (Figure 2.7H). 
We next looked at insulin/Akt signaling in the context of PR. During ischemia, Akt signaling 
was maintained at higher levels in PR mice (Figure 2.7I). Although no consistent differences 
were detected between PR and control mice 30 minutes after reperfusion (Figure 2.7I), 
phosphorylation of the Akt target FoxO1 was clearly increased 3 hours after reperfusion in livers 
of PR vs. Complete diet groups (Figure 2.7J). Importantly, this increase in FoxO1 
phosphorylation was absent in LTsc1KO livers (Figure 2.7J). 
To explain this boost in insulin/Akt signaling 3 hours after reperfusion specifically in WT mice 
preconditioned on PR, we measured serum insulin at multiple time points during the procedure. 
In WT mice, serum insulin levels fell dramatically below preoperative levels during the ischemic 
period independent of diet, and increased gradually following reperfusion (Figure 2.7K). 
Importantly, the recovery of circulating insulin was significantly higher 3 hours after reperfusion 
in PR animals than in control mice. This increase in insulin was unlikely to be secondary to an 
increase in blood glucose, since glucose levels remained significantly lower than initial levels 3 
hrs after reperfusion (Figure 2.7L). As a result of the differential insulin sensitivity between WT 
and LTsc1KO mice, only WT mice displayed the boost in Akt activity upon PR (Figure 2.7J). 
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INCREASED PROSURVIVAL SIGNALING AND REDUCED APOPTOSIS 
CONTRIBUTE TO PR-MEDIATED PROTECTION 
FoxO1 regulates apoptosis via transcription of pro-apoptotic Bcl-2 family members including 
Bim, PUMA and BNIP3 (Zhang et al., 2011). Although hepatic IRI is largely driven by necrotic 
cell death, inhibition of apoptosis protects from injury (Datta et al., 2013). We examined protein 
levels of pro-apoptotic Bcl-2 family members Bik, Bak, PUMA, BID and Bad in WT and 
LTsc1KO animals on PR or control diets for one wk. In WT livers, Bik and BID were reduced 
upon PR, consistent with a decrease in the pro-apoptotic environment (Figure 2.8A). In 
LTsc1KO livers, on the other hand, pro-apoptotic Bcl-2 family members were generally 
expressed at higher levels than in WT livers, and were not reduced upon PR (Bik, Bak and Bad, 
Figure 2.8A). Phosphorylation of Bad at Ser112 and Ser136 can inhibit its binding to Bcl-2 and 
Bcl-xL and thus reduce its pro-apoptotic activity (Danial, 2008). Phosphorylation of Bad at 
Ser112 was decreased upon PR in LTsc1KOs, unlike WTs (Figure 2.8A). Three hours after 
reperfusion, total Bad levels were reduced in WTs upon PR, but remained the same in 
LTsc1KOs with reduced phosphorylation (Figure 2.8B). 
To determine if the observed increase in insulin/Akt signaling and decrease in pro-apoptotic 
factors resulted in reduced apoptosis in WT livers upon PR, sections from livers harvested 3 
hours post-reperfusion were analyzed by TUNEL staining. As expected, WT livers 
preconditioned with PR had significantly less TUNEL positive cells compared to controls, and 
this protective effect of diet was absent in LTsc1KO livers (Figure 2.8C, 2.8D).  
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Figure 2.8 PR results in increased pro-survival signaling and reduced apoptosis in WT, but 
not LTsc1KO livers. 
(A, B) Immunoblots of pro-apoptotic Bcl-2 family members in liver extracts from WT or 
LTsc1KO mice preconditioned on the indicated diets for 1 week and harvested without ischemia 
(A) or 3 hours after reperfusion (B). NI: non-ischemic. 
(C, D) TUNEL staining of non-ischemic or ischemic livers from the indicated diet-genotype 
combinations 3 hours after reperfusion. (C) Quantification was performed by blind scoring of the  
Complete PR Complete PR
WT LTsc1KO
W
T
LT
sc
1K
O
NI 3 hrs post reperfusion
p-Bad (Ser136)
p-Bad (Ser112)
Bad
Bik
Bak
PUMA
BID
cleaved BID
Bad
p-Bad (Ser136)
p-Bad (Ser112)
Complete PR Complete PR
WT LTsc1KO
Actin
A B
D
Comp PR Comp PR0
50
100
150
TU
N
EL
+ 
ce
lls
 / 
fie
ld
*
WT LTsc1KO
C
No
n-
isc
he
m
ic
3 h
rs
po
st
-re
pe
rfu
sio
n
WT - Complete WT - PR LTsc1KO - Complete LTsc1KO - PR
 75 
Figure 2.8 (Continued) 
number of TUNEL+ nuclei/200x field in 10 random fields from each sample, with n = 5 
mice/group. Asterisks indicate the significance of the difference between diets within genotype 
by student’s t test; *p < 0.05.  (D) Representative images of TUNEL-stained sections. Scale bar: 
100 µm. Data in (C) is shown as means ± SD. 
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In order to directly test the role of differential post-reperfusion insulin signaling in PR-mediated 
hepatic IRI protection, we tested the effects of the PI3K inhibitor wortmannin (Ren et al., 2011). 
Treatment 1 hour prior to induction of ischemia increased blood glucose (Figure 2.9A), reduced 
in vivo Akt phosphorylation (Figure 2.9B), and partially abrogated PR-mediated benefits against 
hepatic IRI (Figure 2.9C). Because of the relatively short half-life of wortmannin in vivo, hepatic 
Akt/FoxO signaling was restored by 3 hours after reperfusion (Figure 2.9D), which may explain 
the partial effect. Finally, we tested the response of liver-specific insulin receptor knockout 
(LIrKO) mice (Michael et al., 2000) to PR-mediated hepatic IRI preconditioning. LIrKO mice 
had lower levels of Akt phosphorylation in ischemic liver lobes at 3 hours post reperfusion 
(Figure 2.9E), and their response to PR was worse than WT mice on PR (Figure 2.9F).  
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Figure 2.9 Increased prosurvival signaling and reduced apoptosis contribute to PR-
mediated protection. 
(A) Blood glucose values of mice measured before (0 hr) and 3 hours after reperfusion for the 
experiment described in Figure 6F. Statistical significance was assessed by student’s t-test 
between PR-V and PR-Wmn groups; **p < 0.005, ***p < 0.000001. 
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Figure 2.9 (Continued) 
(B) Immunoblot of Akt phosphorylation in liver extracts from WT mice injected with vehicle or 
1 mg/kg wortmannin 1 hour prior to harvest. 
(C) Serum LDH, ALT and AST activity 3 hours after reperfusion in WT mice preconditioned on 
the indicated diets for 1 week and injected with vehicle or 1 mg/kg wortmannin (Wmn) 1 hour 
prior to hepatic IRI; n = 8-10 mice/group. Statistical significance was assessed by student’s t-test 
between Complete-V and PR-V groups (***p < 0.0005) or between PR-V and PR-Wmn groups 
(#p < 0.05). 
(D) Immunoblots of liver extracts showing markers of Akt signaling; mice that were harvested 3 
hours post-reperfusion, from the experiment described in Figure 6F. 
(E) Immunoblot of liver extracts from WT mice on complete diet, or WT and LIrKO mice 
preconditioned with PR for 1 week and harvested 3 hours after reperfusion. 
(F) Serum LDH, ALT and AST activity before ischemia (0 hr) and 3 hours after reperfusion in 
male WT and LIrKO mice preconditioned on the indicated diets for 1 week prior to hepatic IRI; 
n = 4-5/group. Statistical significance was assessed by student’s t-test between WT-Complete 
and WT-PR groups (***p < 0.0005) or between WT-PR and LIrKO-PR groups (##p < 0.001). 
Data in all panels are shown as means ± SD. 
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A model for the collective action of PR on increased insulin sensitivity and relative insulin levels 
in WT animals after ischemia and reperfusion, resulting in increasing pro-survival signaling and 
reduced cell death, is presented in Figure 2.10. These latter effects were dependent on the 
expression of TSC1 in hepatocytes and were partially blocked by genetic and pharmacological 
inhibition of insulin/Akt signaling. 
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Figure 2.10: Model of TSC/mTORC1 function and insulin sensitivity in PR-mediated 
hepatic stress resistance. 
A model for the effects of dietary protein or tryptophan restriction on improved hepatic insulin 
sensitivity prior to an acute ischemia event. After reperfusion, increased insulin levels and 
increased hepatic insulin sensitivity facilitate pro-survival signaling and contribute to protection 
from injury. 
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DISCUSSION 
Previously we reported a genetic requirement for Gcn2 in mediating surgical stress resistance 
upon single EAA restriction (Peng et al., 2012). Here we found that GCN2 was no longer 
required when total protein was removed from the diet, suggesting involvement of a redundant 
nutrient-sensing pathway. We thus tested the role of the mTORC1 pathway using mice deficient 
in Tsc1 with constitutive mTORC1 activation specifically in the liver. The role of the 
mammalian TSC complex in DR benefits has not been previously tested. Here we found that two 
major benefits of PR, namely improved hepatic insulin sensitivity and stress resistance, both 
required the TSC complex. 
Consistent with intact Ragulator-based mechanisms of mTORC1 inhibition in vitro, TSC1KO 
hepatocytes had higher baseline levels of mTORC1 activity but were still responsive to amino 
acid deprivation. Nonetheless, hepatic mTORC1 activity in vivo was completely recalcitrant to 
total dietary protein restriction in LTsc1KO vs. WT livers, despite reduced serum and liver free 
amino acids and activation of the GCN2-dependent amino acid starvation response in both 
genotypes. Our interpretation of these data is that the concentration of leucine or other critical 
amino acids required to trigger Ragulator-based mTORC1 inhibition can be achieved by removal 
of free amino acids in vitro, but cannot be achieved in vivo due to the buffering capacity on the 
organismal level against drastic changes in steady-state levels of free amino acids. What level of 
free amino acids are required to activate Ragulator in hepatocytes in vivo, and whether longer 
periods of dietary protein deprivation, or combined protein and calorie deprivation such as 
fasting, ever result in a drop below these levels, remains to be determined. 
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While female LTsc1KO mice almost entirely lost the preconditioning benefit of PR against 
hepatic IRI, parallel experiments in males showed that despite similar functional protection by 
PR as in females, this protection was only partially lost in LTsc1KO males. Although the reason 
for this apparent sex-based difference in the genetic requirement for Tsc1 is unclear, we note that 
the lifespan extension benefits of ablation of the downstream mTORC1 target S6K and mTOR+/-
mLST8+/- models are also preferentially observed in females (Selman et al., 2009, Lamming et 
al., 2012). 
In addition to total protein restriction, we also tested the effects of tryptophan restriction on 
LTsc1KO mice. Interestingly, LTsc1KO mice exhibited a response comparable to WT mice. 
Together with the previous findings indicating a requirement for the amino acid deprivation 
sensor GCN2 in protection afforded by tryptophan restriction (Peng et al., 2012), these results 
suggest that GCN2 and mTORC1 may act in parallel pathways, eventually converging on the 
same beneficial outcome. Whether or not this occurs through a common downstream mechanism 
remains to be determined. However, the lack of improvement of insulin sensitivity in GCN2KO 
mice in response to leucine restriction (Xiao et al., 2011) is consistent with the possibility of 
improved hepatic insulin sensitivity as a potential point of convergence.  
Inhibition of TOR signaling has been implicated in longevity, metabolism and stress resistance, 
including the response to DR in lower organisms, but its downstream effector mechanisms in 
mammals are not well established (Kaeberlein et al., 2005, Zid et al., 2009, Kaeberlein, 2013). 
Improved insulin sensitivity is a metabolic hallmark of multiple different DR regimens, 
including PR (Fontana et al., 2010, Toyoshima et al., 2010), and is potentially controlled in part 
by mTORC1-based feedback inhibition of IRS-1 (Howell and Manning, 2011). Here, we found 
that improved hepatic insulin sensitivity upon PR required the TSC complex. Interestingly, PR 
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appeared to reduce hepatic insulin sensitivity in LTsc1KOs, although the reason for this remains 
unclear. 
The fact that both increased and decreased signaling through the evolutionarily conserved 
insulin/IGF-1 pathway can improve cellular stress resistance and organismal survival is 
paradoxical (Rincon et al., 2004, Tang, 2006). Reduced insulin signaling, due either to reduced 
insulin levels as with DR, or in constitutive genetic models of reduced insulin/IGF-1 signaling, 
can extend longevity and increase stress resistance in part through activation of cytoprotective 
gene expression normally inhibited by insulin/Akt signaling. For example, in C. elegans, 
activation of FoxO/Daf-16 targets involved in stress resistance has been implicated in DR 
mediated longevity (Greer et al., 2009). On the other hand, increased insulin action is desirable 
under certain circumstances, for example to promote cell survival after ischemic insult. 
Consistent with this, increased insulin/PI3K/Akt signaling has been shown to play a protective 
role in both the rat isolated heart ischemia model (Jonassen et al., 2001, Fuglesteg et al., 2009, 
Liu et al., 2007) and other hepatic IRI models (Kamo et al., 2013) where a protective effect of 
reduced apoptosis has been described (Datta et al., 2013). 
Our model of improved insulin sensitivity upon PR provides an answer to this apparent paradox. 
During the preconditioning period prior to injury, reduced insulin levels and reduced insulin-
dependent mTORC1 activity were required, not to increase expression of cytoprotective FOXO 
or NRF2 target genes, but to facilitate improved insulin sensitivity via a decrease in mTORC1 
feedback inhibition. This occurred in WT livers on PR, but was prevented in LTsc1KO livers 
due to constitutive mTORC1 activation. After injury, increased insulin signaling led to increased 
inhibitory FoxO1 phosphorylation, reduced apoptosis and improved outcome in insulin-sensitive 
WT livers. Inhibition of post-reperfusion insulin signaling either pharmacologically via the PI3K 
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inhibitor wortmannin, or genetically with LIrKO mice, partially abrogated PR-mediated 
protection. Whether or not IGF-1 plays a role similar to insulin remains to be tested. Although 
hepatic IGF-1R expression is low, liver-specific deletion compromises regeneration (Desbois-
Mouthon et al., 2006); furthermore, IGF-1 can activate the insulin receptor directly. Thus 
whether insulin alone or a combination of insulin and IGF-1, our model predicts decreased 
growth factor signaling prior to injury (resulting in increased insulin/IGF-1 sensitivity) and 
increased signaling after injury are both required for maximal protection. It is important to note 
that because abrogation of insulin signaling only partially blocked PR-mediated protection, 
additional mechanisms contributing significantly to protection remain to be identified. 
Understanding the mechanistic basis of DR is crucial to the development of potential 
interventions that mimic its beneficial effects. Genetic and pharmacological approaches targeting 
nutrient sensing pathways have yielded similar results to DR in terms of longevity extension and 
other beneficial health effects, suggesting a causal role for the downregulation of these pathways 
in DR benefits (Fontana et al., 2010, Kaeberlein, 2013). For example, rapamycin extends 
lifespan in rodents, although what aspect of mTORC1 inhibition is responsible remains unclear 
(Harrison et al., 2009, Miller et al., 2011, Miller et al., 2013). Despite longevity extension, 
rapamycin has negative side effects, including increased inflammation and reduced insulin 
sensitivity (Lamming et al., 2013) and fails to recapitulate many other DR phenotypes (Miller et 
al., 2013). In our model, rapamycin not only failed to recapitulate benefits of PR, but partially 
abrogated PR benefits, possibly due to its aforementioned negative effects on insulin signaling 
via mTORC2 inhibition (Lamming et al., 2013).  
Hepatic IRI presents a major challenge during various clinical contexts such as hepatic resection 
and liver transplantation surgeries, as well as trauma (Datta et al., 2013, Klune and Tsung, 2010). 
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Ischemic damage to other tissues, including heart, brain and kidney, occurs regularly as an 
unintended complication of cardiovascular surgery, leading to significant morbidity and 
mortality (Mitchell et al., 2013). Understanding the mechanistic basis of DR-mediated protection 
could lead to preventative strategies against these clinically relevant stressors. 
 
MATERIALS AND METHODS 
Animals and Diets 
All animal experiments were performed with the approval of the appropriate institutional animal 
care and use committee. WT C57Bl/6J mice were purchased from Jackson Laboratories at 8-10 
weeks of age. LTsc1KO and GCN2KO mice were backcrossed on the C57Bl/6J background as 
described previously (Yecies et al., 2011, Menon et al., 2012, Peng et al., 2012). Irfl/fl mice as 
described previously (Michael et al., 2000) were purchased from the Jackson Laboratories 
(B6.129S4(FVB)-Insrtm1Khn/J, Stock #006955). Experimental LTsc1KO and littermate control 
animals were generated by crossing Tsc1fl/fl (WT) mice with Tsc1fl/fl|Albumin-Cre +/- (LTsc1KO) 
mice; GCN2KO and control mice were generated by crossing heterozygotes; LIrKO and control 
mice were generated by crossing Irfl/fl (WT) mice with Irfl/fl|Albumin-Cre+/- (LIrKO) mice. 
Animals were kept under standard housing conditions with ad libitum access to food (Purina 
5058) except for the indicated dietary treatments. Female mice between 10-16 weeks of age were 
used unless otherwise indicated. LTsc1KO mice were used prior to the age of 16 weeks in order 
to avoid any potential complications of hepatocellular carcinomas, which appear later in life 
(Menon et al., 2012).  
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Dietary and Pharmacological Treatments of Mice 
Experimental control diets were based on a modified version of Research Diets D12450B 
prepared with 18% calories from protein (individual crystalline amino acids (Ajinomoto) based 
on the proportions present in casein), 10% from fat (lard, soybean oil) and 72% from 
carbohydrate (sucrose, maltodextrin, corn starch). For protein free and individual amino acid free 
diets, missing amino acids were replaced with isocaloric sucrose. All diets were prepared in a 
final 1% agar mixture. Mice on experimental diets were fed and weighed daily, at the same time 
of the day. When mice were subject daily to reduced food availability (dietary restriction, DR), 
they tended to eat their daily allotment quickly, resulting in periods of extended fasting for the 
remainder of the 24-hour period. However, when presented with incomplete diets lacking protein 
or essential amino acids, mice self-restricted food intake by up to 30-35% (Peng et al., 2012). As 
a result, even when availability of protein or amino acid deficient diets was restricted daily by 
35%, animals did not eat the available food quickly (as with DR) and thus didn’t experience 
extended periods of fasting. Procedures including surgery and tissue harvesting were performed 
in the morning without prior fasting unless otherwise indicated. Rapamycin for in vivo use was 
purchased from LC Laboratories, dissolved in 100% EtOH and diluted in sterile 5% Tween-
80/5% PEG-400 solution for i.p. injections. Wortmannin was purchased from Selleckchem, 
dissolved in DMSO and diluted in sterile 30%PEG/1%Tween-80 solution for i.p. injections. 
Hepatic Ischemia Reperfusion Injury and Serum Damage Assays 
Hepatic IRI was performed by placing a microvascular clamp (Roboz) over the portal triad for 
35 minutes for female and 30 minutes for male mice as described previously (Peng et al., 2012). 
After surgery, mice were given ad libitum access to control diet starting at 3 hours after 
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reperfusion. Serum ALT and AST levels were measured using Infinity Reagents (Thermo 
Scientific) and serum LDH levels using Pointe Scientific reagents with kinetic absorbance assays 
in a 384-well format with a BioTek Synergy II plate reader and calculated according to 
manufacturer’s instructions. For histology, median lobes were formalin fixed, paraffin embedded, 
cut into 5-micron sections and stained with hematoxylin and eosin or TUNEL (Promega). 
Percentage of necrotic area or TUNEL positivity in each section was scored blindly.  
Primary Dermal Fibroblast and Primary Hepatocyte Isolation and Treatments 
Mouse dermal fibroblasts were isolated from tail skin by mincing into fine slices followed by 
overnight collagenase treatment (Invitrogen Collagenase II). Cells were cultured in DMEM with 
20% FBS at 3% oxygen tension. Primary hepatocytes were isolated via portal vein collagenase 
treatment (Liberase, Roche) followed by Percoll gradient centrifugation and cultured in 
William’s E media with 5% FBS. Amino acid free DMEM was a special formulation of 
Invitrogen DMEM-12320. For the amino acid add-back, either MEM amino acid solution 
(GIBCO) was used at 1x concentration, or individual amino acids were added back to AA-free 
medium up to their original concentrations in DMEM, and supplemented with 10% dialyzed FBS 
(Invitrogen). Rapamycin was purchased from Calbiochem. 
Serum Measurements and Amino Acid Analysis 
Blood glucose was measured with an Easy Step glucometer (Home Aide Diagnostics). Serum 
insulin and IGF-1 levels were measured with ELISA assay kits (Alpco). Serum and liver free 
amino acid analyses were performed by mass spectrometry and normalized by volume and total 
protein content, respectively. 
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Western Blotting 
Cells and tissues were homogenized in NP-40 lysis buffer, cleared by centrifugation, separated 
by SDS-PAGE and transferred to PVDF membranes for blotting. Primary antibodies were 
purchased from Cell Signaling Technology except anti-p-BadSer136 and IR" (Santa Cruz), and 
secondary antibodies from Dako. 
Serum damage measurements using Piccolo Liver Plus Panel discs 
Piccolo Liver Plus Panel discs (Abaxis) were used as a second platform for confirming ALT and 
AST levels according to the manufacturer’s instructions. This platform can measure serum ALT 
and AST levels up to 2000 IU/L. For the mice which had damage values greater than 2000, we 
estimated these values to be 2000 IU/L and performed calculations accordingly. 
RNA isolation and quantitative PCR 
Total RNA was isolated from frozen tissues by RNA Bee reagent (Qiagen) and cDNAs were 
synthesized by using random hexamer primers and Verso cDNA synthesis kit (Thermo 
Scientific) according to the manufacturer’s instructions. SYBR green dye was used for 
quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and fold changes were 
calculated by ##Ct method using Hprt housekeeping gene. Each sample was tested in duplicates. 
Primer sequences for each gene are listed in Table 2.1. 
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Table 2.1 qRT-PCR Primer sequences 
Gene Forward primer (5' !  3') Reverse primer (5' !  3') 
Asns GTCAAGAACTCCTGGTTCAAG GATCTGACGGTAGAAGTAGC 
4ebp1 ACTAGCCCTACCAGCGATGAG CGCAGACATAGAAGCATCATTGCG 
Nrf2 AGGACATGGAGCAAGTTTGG TCTGTCAGTGTGGCTTCTGG 
Nqo1 AGGATGGGAGGTACTCGAATC AGGCGTCCTTCCTTATATGCTA 
Ho1 AAGCCGAGAATGCTGAGTTCA GCCGTGTAGATATGGTACAAGGA 
Gclc GGGGTGACGAGGTGGAGTA GTTGGGGTTTGTCCTCTCCC 
Gclm AGGAGCTTCGGGACTGTATCC GGGACATGGTGCATTCCAAAA 
Gss CAAAGCAGGCCATAGACAGGG AAAAGCGTGAATGGGGCATAC 
Gstm4 AGCTCACGCTATTCGGCTG GCTCCAAGTATTCCACCTTCAGT 
Gsta4 TGATTGCCGTGGCTCCATTTA CAACGAGAAAAGCCTCTCCGT 
Gsta3 AAGAATGGAGCCTATCCGGTG CCATCACTTCGTAACCTTGCC 
Catalase TCCCTGCTGTCTCACGTTCC CGGGTCTCCTATTGGGTTCCCG 
Sod1 GGGACAATACACAAGGCTGT GCCAATGATGGAATGCTCTC 
Hprt TTTCCCTGGTTAAGCAGTACAGCCC TGGCCTGTATCCAACACTTCGAGA 
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Statistical Analyses 
All data are represented as means ± standard deviations (SD). Statistical significance was 
assessed by student’s t test for pairwise comparisons or by one-way analysis of variance 
(ANOVA) with post-hoc tests as indicated using Microsoft Excel or GraphPad Prism. P-values 
smaller than 0.05 were considered statistically significant. Quantification of western blot images 
was done by ImageJ software. 
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CHAPTER 3  
 
TSC1KO LIVERS HAVE IMPAIRED ABILITY TO UPREGULATE H2S 
PRODUCTION CAPACITY IN RESPONSE TO DIETARY PROTEIN RESTRICTION 
 
Part of the data presented in this chapter was originally published in: 
Hine, C.1, Harputlugil, E.1, Zhang, Y.1, Ruckenstuhl, C.4, Lee, B.2 C., Brace, L.1, Longchamp, 
A.1,3, Trevino-Villarreal, J. H.1, Mejia, P.1, Ozaki, C. K.3, Wang, R.6, Gladyshev, V. N.2, Madeo, 
F.4,5, Mair, W. B.1 & Mitchell, J. R.1 2015. Endogenous hydrogen sulfide production is essential 
for dietary restriction benefits. Cell, 160, 132-44. 
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SUMMARY 
Dietary restriction or protein restriction (DR/PR) provides multiple beneficial effects on health 
across evolutionary boundaries, but the underlying molecular mechanisms remain poorly 
understood. Previously, we identified a genetic requirement for the mTORC1 repressor TSC 
complex in mediating PR effects on protection from hepatic ischemia reperfusion injury (IRI), in 
part through facilitating pro-survival signaling upon PR. Recently, our group established a 
connection between DR/PR and increased endogenous hydrogen sulfide (H2S) production 
through the transsulfuration enzyme cystathionine $-lyase (CGL). Here, we show that LTsc1KO 
mice failed to upregulate hepatic CGL expression and H2S production upon PR, thus providing 
an additional mechanism by which these mice fail to gain PR-mediated protection from hepatic 
IRI. These data implicate the TSC/mTORC1 pathway in control of endogenous hepatic H2S 
production in vivo. Interestingly, primary hepatocytes from LTsc1KO mice maintained H2S 
production capacity in culture, suggesting an important role for systemic factors in vivo in the 
regulation of H2S production. 
 
BACKGROUND  
Hydrogen sulfide (H2S) is a colorless, foul smelling gas, which is toxic and considered a health 
hazard at high doses. Nonetheless, it has recently emerged as a biologically relevant molecule 
with important, beneficial effects on physiology and health at lower doses. For example, 
exogenous administration of H2S induces a state of “suspended animation” characterized by 
reduced body temperature and decreased energy metabolism that is protective against hypoxia in 
mice (Blackstone et al., 2005). H2S also protects against ischemia reperfusion injury to different 
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organs including heart and liver in mice (Predmore and Lefer, 2010, Kang et al., 2009), and 
increases longevity in worms (Miller and Roth, 2007). Due to these beneficial effects, H2S is 
currently being investigated as a therapeutic agent in the area of cardiovascular disease 
(Predmore and Lefer, 2010, Zhang et al., 2013).  
In addition to low-level exogenous H2S as a source of potential health benefits, organisms 
ranging from yeast to mammals can also produce H2S endogenously via a number of 
evolutionarily conserved mechanisms (Paul and Snyder, 2012). In mammals, H2S can be 
produced by the actions of two different enzymes of the transsulfuration pathway (TSP), 
cystathionine "-synthase (CBS) and cystathionine $-lyase (CGL, also referred to as CSE or CTH). 
The TSP is essential for de novo cysteine production, and is the reason that cysteine is a non-
essential amino acid in humans. Following the conversion of the essential amino acid methionine 
into homocysteine via the transmethylation pathway, CBS converts homocysteine into 
cystathionine, followed by the action of CGL to produce cysteine. Interestingly, CGL and CBS 
can each use these TSP substrates and products (namely homocysteine and cysteine) to generate 
H2S, while at the same time producing serine, pyruvate or alpha-ketobutyrate (Paul and Snyder, 
2012). CGL is thought to be the predominant source of H2S in peripheral tissues including the 
liver (Yang et al., 2008, Kabil et al., 2011b), while CBS likely plays a more important role in 
H2S production in the brain (Linden et al., 2008). A third enzyme, 3-mercaptopyruvate 
sulfurtransferase (MST), can produce H2S from 3-mercaptopyruvate (Wang, 2012). 
The importance of endogenous CGL-derived H2S was first recognized in the context of 
vasodilation, as mice lacking CGL (CGLKO) suffer from high blood pressure and cardiovascular 
disease (Yang et al., 2008). CGLKO mice are also susceptible to Huntington’s disease, 
implicating the importance of physiological levels of this gas in protection from 
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neurodegenerative disease (Paul et al., 2014). H2S is also implicated in regulation of a wide 
range of biological processes, from inflammation (Grou et al., 2012)  to insulin secretion (Xue et 
al., 2013) to angiogenesis (Papapetropoulos et al., 2009). Consistent with the importance of this 
metabolite in humans, reduced H2S in circulation correlates with congestive heart failure 
(Kovacic et al., 2012).  
On a molecular level, H2S likely mediates its beneficial effects through numerous mechanisms. 
The major mechanism of action is thought to be post-translational modification of target proteins 
via “sulfhydration” of surface-exposed cysteine residues, which can affect target protein function 
(Mustafa et al., 2009). For example, sulfhydration of Cys38 of NFkB subunit p65 increases it 
antiapoptotic activity (Grou et al., 2012), while sulfhydration of the KATP channel subunit Kir6.1 
activates the channel, reducing insulin secretion e.g. in pancreatic beta cells (Kimura, 2011). 
Alternately, H2S can work directly as an antioxidant (Li et al., 2011), or can donate electrons to 
the mitochondrial electron transport chain through the evolutionarily conserved protein SQR, 
thus potentially contributing to ATP generation (Modis et al., 2013).  
Regardless of how H2S mediates its biological effects, the importance of its potential therapeutic 
uses is clear. Our group recently showed that upregulation of CGL expression and H2S 
production upon dietary sulfur amino acid or protein restriction (commonly referred to as DR 
here) is necessary and sufficient for multiple DR mediated-health benefits ranging from surgical 
stress resistance in mice to extended longevity in worms (Hine et al., 2015, Shim and Longo, 
2015). This finding is consistent with the requirement of TSP for DR-mediated longevity 
extension in flies (Kabil et al., 2011a). 
 100 
Given that impaired insulin sensitivity only partially explains the lack of protein restriction (PR)-
mediated protection from hepatic ischemia reperfusion injury in liver-specific tuberous sclerosis 
complex 1 knockout (LTsc1KO) livers (explained in Chapter 2) (Harputlugil et al., 2014), here 
we investigated the potential role of impaired H2S production in those livers as an additional 
mechanism of their unresponsiveness to PR. 
 
RESULTS 
LTSC1KO LIVERS HAVE IMPAIRED H2S PRODUCTION CAPACITY IN 
RESPONSE TO PROTEIN RESTRICTION 
In order to identify additional potential mechanisms that might underlie the lack of a PR 
response in LTsc1KO livers, we took an unbiased metabolomics approach to search for 
metabolites that were significantly affected by PR in WT but not LTsc1KO livers. Although free 
amino acids such as methionine and cysteine were reduced in both genotypes on PR as expected 
due to dietary protein restriction, we observed two intermediates that fit the expected pattern 
(Figure 3.1A, B). Interestingly, both of these the metabolites, serine and homoserine, are also 
byproducts of H2S production by the TSP enzymes CBS and CGL (Figure 3.1C). Because we 
already suspected involvement of the TSP based on the finding that dietary cysteine negated PR-
mediated protection from hepatic IRI (Hine et al., 2015), as well as the known potential of 
exogenous H2S in protection from ischemic injury (Predmore and Lefer, 2010), we decided to 
measure H2S generating enzymes and H2S production capacity directly in these samples.   
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Figure 3.1 LTsc1KO livers have impaired H2S production capacity in response to protein 
restriction. 
(A, B) WT or LTsc1KO mice were fed with complete ad libitum diet (AL) or 35% protein-free 
diet (PR) for one week prior to liver harvest. Liver metabolites were measured by unbiased LC-  
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Figure 3.1 (Continued) 
MS metabolomics and normalized to protein content. For each metabolite, levels are expressed 
as fold change compared to the WT ad libitum-fed group (WT AL); n = 4-5 mice per group. 
Asterisks indicate the statistical significance of the difference between the different dietary 
regimens according to a Student’s t-test; * p<0.05. (EH) 
(C) Model showing transmethylation and transsulfuration pathways. Arrows trace sulfur from 
Met to Cys and downstream cellular processes via cystathionine beta-synthase (CBS) and 
cystathionine gamma-lyase (CGL). MAT, methionine adenosyl transferase; SAM: S-
adenosylmethionine; SAH, S-adenosylhomocysteine; SAHH, S-adenosylhomocysteine 
hydrolase; MS, methionine synthase; BHMT, betaine homocysteine methyltransferase. (CH) 
(D, E) H2S production (D) and immunoblots of liver CGL (E) and in WT and LTsc1KO mice fed 
AL or 35% DR on a protein-free diet (PR). n = 5 mice/group (D), n = 3 mice/group (E). (EH, 
CH) 
(F, G) mRNA levels of Cgl and Cbs (F) and H2S production (G) in livers of WT and LTsc1KO 
mice treated with either vehicle (V) or rapamycin injections (1mg/kg) for up to 4 days as 
indicated. n = 2-3 mice per treatment group (F, G), technical triplicates are shown side by side 
for each mouse (G). Asterisks indicate the statistical significance of the difference between the 
indicated groups according to 1-way ANOVA against LTsc1KO-V group, with post-hoc 
Dunnett’s multiple comparisons test; * p<0.05. (EH) 
Data in all panels are shown as means ± SD. 
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To measure H2S production capacity, we employed the lead sulfide method in which H2S gas in 
the headspace above a reaction mixture containing a source of H2S-generating enzyme together 
with substrate (L-cysteine) and cofactor (pyridoxal-5'-phosphate, or PLP) is captured on lead 
acetate-soaked filter paper as the black precipitate, lead sulfide. We measured the H2S 
production capacity of lysates from livers of WT and LTsc1KO mice upon PR. We observed that 
LTsc1KO livers had lower H2S production capacity compared to WT livers upon PR (Figure 
3.1D). This differential H2S production capacity correlated with the protein levels of CGL 
enzyme in liver lysates (Figure 3.1E).  
In order to confirm that these changes were mTORC1-specific, we tested the H2S production 
capacity and Cgl/Cbs mRNA levels in LTsc1KO liver lysates upon treatment with the mTORC1 
inhibitor rapamycin for up to 4 days. Even though the effect of rapamycin was not clear at the 
Cgl mRNA level (Figure 3.1F), H2S production capacity was markedly increased in LTsc1KO 
livers upon rapamycin treatment by day 3 of treatment (Figure 3.1G). Taken together, these data 
show that LTsc1KO mice are impaired in their ability to upregulate hepatic H2S production 
capacity in response to PR, potentially via effects on CGL expression. 
THE EFFECTS OF CONSTITUTIVE MTORC1 ACTIVATION ON H2S 
PRODUCTION ARE NOT CELL AUTONOMOUS, AND PR MEDIATED H2S 
PRODUCTION LIKELY INVOLVES OTHER PATHWAYS 
Next, we wanted to understand the role of the mTORC1 pathway in regulation of H2S production 
on a cell autonomous level using an in vitro primary hepatocyte model. Interestingly, unlike in 
liver extracts in which H2S production was consistently reduced independent of diet (Figure 
3.2A), we observed no differences in H2S production capacity of hepatocytes from LTsc1KO vs.  
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Figure 3.2 The effects of constitutive mTORC1 activation on H2S production are not cell 
autonomous, and PR mediated H2S production likely involves other pathways. 
(A) Livers (left) or primary hepatocytes (right) were isolated from one WT and one LTsc1KO 
mice, and H2S production capacity was measured by the lead-acetate paper method either in liver 
lysates or in live cultured hepatocytes that were treated with complete or serum- (FBS) media 
overnight. (EH) 
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Figure 3.2 (Continued) 
(B) H2S production of WT and LIrKO mice either fed ad libitum complete or 35% DR on a 
protein-free diet (PR) as indicated; n = 5-6 mice per treatment group, technical duplicates are 
shown side by side. (EH) 
(C) Immunoblots of WT and LIrKO mice either fed ad libitum complete or 35% DR on a 
protein-free diet (PR); n = 4 mice per group. CGL KO lysate was used as control for the CGL 
band as shown with arrow, and the quantification if the CGL band is shown on the right. ## 
p<0.001 according to Student’s T test. Data are shown as means ± SD. (EH) 
(D) mRNA levels of Asns, Cgl and Cbs in livers of WT and LIrKO mice either fed ad libitum 
complete or 35% DR on a protein-free diet (PR); n = 5-6 mice per group. Asterisks indicate the 
statistical significance between the indicated groups according to a Student’s T test; * p<0.05, ** 
p<0.005, *** p<0.0001, ## p<0.001. (EH) 
Data in all panels are shown as means ± SD. 
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WT livers. Furthermore, overnight serum deprivation, which is sufficient to increase H2S 
production in WT hepatocytes (Figure 3.2A; see also Chapter 4), was also able to increase H2S 
production in LTsc1KO hepatocytes. Thus, the reduced baseline and inability to upregulate H2S 
production upon PR observed in LTsc1KO livers was not recapitulated in the primary hepatocyte 
system. While the reason for this is not clear, it could either be an in vitro artifact related to 
differences in cultured LTsc1KO hepatocytes (e.g. greatly reduced plating efficiency vs. WT, 
data not shown), or could suggest a role for systemic factors in the regulation of H2S production 
in the LTsc1KO model. 
In addition to constitutive mTORC1 activation, LTsc1KO livers exhibit insulin resistance as 
discussed in detail in Chapter 2. Because the PI3K/Akt pathway has been implicated in 
regulation of Cgl expression and hence H2S production (Zhao et al., 2014, Yin et al., 2012), we 
hypothesized a potential role of impaired insulin/Akt signaling in reduced H2S production 
capacity in LTsc1KO livers in vivo. To test this, we investigated H2S production capacity in 
liver-specific insulin receptor knockout (LIrKO) mice. Relative to livers of WT mice on PR, 
livers of LIrKO mice on PR had reduced H2S production capacity, Cgl mRNA and protein levels 
(Figure 3.2B-D). As a control for successful amino acid deprivation in livers of LIrKO mice 
upon PR, ATF4 target Asns mRNA levels were significantly elevated in both genotypes relative 
to WT mice on a complete diet.  
Taken together, our data are consistent with growth factor/Akt signaling playing a role in H2S 
regulation in vivo, and more specifically, hepatic insulin resistance as a negative regulator of 
CGL expression and H2S production capacity rather than mTORC1 signaling per se. Future 
experiments are required to delineate the details of this regulation. 
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DISCUSSION 
In Chapter 2, we identified a genetic requirement for the TSC complex in hepatocytes in the 
protection afforded by dietary protein restriction (PR) against hepatic IRI (Harputlugil et al., 
2014). Using this LTsc1KO model, we uncovered a mechanistic requirement for insulin 
sensitivity that could account for some, but not all, of the protection afforded by PR against 
hepatic IRI. Here, we used the same model to identify an additional requirement for increased 
CGL expression and H2S production contributing to protection by PR against hepatic IRI.  
Using an unbiased metabolomics approach, we identified intermediates of the transsulfuration 
pathway that were differentially regulated in LTsc1KO livers upon PR. Steady-state levels of 
homoserine and serine, which are byproducts of CBS and CGL in the production of H2S, were 
significantly increased in WT livers upon PR. Despite the fact that H2S itself is not detectable on 
our metabolomics platform, considering the beneficial role of H2S in stress resistance (Predmore 
and Lefer, 2010), we investigated the link between endogenous H2S production and DR-
mediated benefits. Using the lead acetate method to directly measure H2S production capacity in 
liver extracts, we established that endogenous H2S is necessary and sufficient for DR-mediated 
protection from hepatic IRI (Hine et al., 2015). The observation that LTsc1KO livers had 
reduced baseline H2S production capacity (Figure 3.1G; 3.2A) and failed to upregulate H2S 
production upon PR (Figure 3.1D), indicates that H2S plays a role in the failure of LTsc1KO 
mice to respond to PR. Furthermore, the low baseline H2S production capacity phenotype was 
reversible upon rapamycin treatment, suggesting that constitutive mTORC1 activation prevents 
baseline and activated H2S levels. Interestingly, however, rapamycin treatment did not increase 
H2S production capacity to levels observed upon DR, suggesting that while mTORC1 
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constitutive activation can repress H2S production capacity, a different mechanism that remains 
to be elucidated is required to increase H2S production capacity upon PR. 
In order to investigate the mechanism by which mTORC1 signaling repressed CGL expression 
and H2S production on a cell autonomous level, we modeled DR in primary hepatocytes in vitro 
by culturing them under conditions of serum deprivation. Contrary to what we observed in vivo, 
Tsc1KO hepatocytes produced as much H2S as WT cells under complete media conditions and 
responded normally to serum deprivation by increasing H2S production capacity. There could be 
multiple reasons for this discrepancy. On the one hand, LTsc1KO hepatocytes are far less able to 
survive the isolation procedure than WT hepatocytes, which could potentially increase H2S 
production through mechanisms unrelated to mTORC1 or TSC. On the other hand, it could also 
indicate the importance of systemic factors regulated by DR in vivo that are lost in the in vitro 
system, such as hormones and growth factors. The fact that LIrKO livers respond to PR similarly 
as LTsc1KO livers indicates that reduced insulin/Akt signaling might be playing a role as 
previously suggested (Zhao et al., 2014, Yin et al., 2012), however further studies are needed to 
establish a clear connection. 
There are two important open questions remaining. How does DR/PR regulate CGL expression 
and H2S production? And how does H2S mediate its beneficial health effects such as protection 
from surgical stress? Both of these questions clearly require further investigation and will have 
broad implications in terms of both understanding how dietary restriction works and how H2S 
can be used in clinical settings. 
 
MATERIALS AND METHODS 
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Animal models, dietary and pharmacological treatments 
Breeding and maintenance of LTsc1KO and LIrKO mice, housing conditions, experimental 
animal diets and in vivo rapamycin treatment protocol were described in Chapter 2.  
Metabolomics   
Liver metabolites were extracted on dry ice using 80% methanol, samples were dried and 
resuspended in H2O right before analysis by LC-MS at a Harvard core facility. Levels were 
normalized to total protein content.  
H2S measurements by Lead Sulfide Method 
For H2S measurements, snap-frozen liver tissue was homogenized in passive lysis buffer 
(Promega), lysate was flash frozen in LN2 and thawed at 37°C once for complete lysis, and 
cleared by centrifugation. Sample amounts were equalized by protein content, and 10mM L-
cysteine and 10mM PLP was added as substrate and cofactor to the reaction. Lead-acetate papers 
were prepared by soaking filter paper (VWR) in 20mM lead acetate and vacuum drying. H2S 
reaction mixtures were placed in closed containers with the lead-acetate paper above the liquid 
phase, and able to capture the produced H2S gas. Samples were incubated at 37°C until the 
brown colored lead sulfide precipitate started to become visible. 
Western Blotting 
Frozen tissues were lysed in NP-40 lysis buffer and separated by SDS-PAGE. PVDF membranes 
were used for blotting. Membranes were blocked with 5% dry milk for 1 hour at RT and 
incubated O/N in primary antibodies at 4°C. Primary antibodies: Actin (#4970 Cell Signaling 
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Technology), CGL (ab151769 Abcam), CBS (ab135626 Abcam), IR-" (sc-711 Santa Cruz 
Biotechnology) and secondary antibodies from Dako. 
RNA isolation and quantitative PCR 
Total RNA isolation, cDNA synthesis and qRT-PCRs were performed as described in Chapter 2. 
Primer sequences for each gene are listed in Table 3.1. 
Table 3.1 qRT-PCR Primer sequences 
Gene Forward primer (5' !  3') Reverse primer (5' !  3') 
Hprt TTTCCCTGGTTAAGCAGTACAGCCC TGGCCTGTATCCAACACTTCGAGA 
18S CATGCAGAACCCACGACAGTA CCTCACGCAGCTTGTTGTCTA 
Cgl TTGGATCGAAACACCCACAAA AGCCGACTATTGAGGTCATCA 
Cbs GGGACAAGGATCGAGTCTGGA AGCACTGTGTGATAATGTGGG 
 
Statistical analyses 
Data in all panels are represented as means ± standard deviations (SD). Statistical analyses were 
performed as described in Chapter 2. 
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CHAPTER 4 
 
REGULATION OF ENDOGENOUS H2S PRODUCTION 
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SUMMARY 
Hydrogen sulfide (H2S) is now recognized as a biological molecule with a range of beneficial 
health effects, including increased stress resistance and extended longevity in lower organisms. 
Our group has recently shown that dietary restriction (DR) stimulates endogenous H2S 
production via increased cystathionine $-lyase (CGL) expression, and that H2S is an important 
mediator of beneficial DR effects. Despite the wide range of potential implications of these 
findings, the mechanisms regulating endogenous H2S production, including CGL transcriptional 
control and the source of free cysteine in substrate-level control of H2S production, remain 
poorly understood. Here we investigated the role of growth hormone (GH) signaling in 
regulation of H2S production and the role of autophagy as a potential source of substrate for H2S 
generation. We identified GH as a negative regulator of hepatic H2S production in vivo in part 
through transcriptional repression of hepatic CGL expression. In addition, GH rapidly repressed 
H2S production in hepatocytes in vitro independent of transcriptional control of Cgl or Cbs 
through an unknown mechanism. Additionally we demonstrated that stimulation of H2S 
production via serum deprivation requires functional autophagy, likely as a source of free 
cysteine for H2S generation by CGL. The detailed mechanisms of GH-mediated H2S regulation, 
and whether there is a crosstalk between reduced GH signaling and increased autophagy leading 
to increased H2S production, remain important topics to be further investigated. 
 
BACKGROUND  
In mammalian cells, endogenous hydrogen sulfide (H2S) is primarily produced by the actions of 
the transsulfuration pathway (TSP) enzymes cystathionine "-synthase (CBS) and cystathionine $-
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lyase (CGL, also referred to as CSE or CTH) (Paul and Snyder, 2012) as described in more detail 
in Chapter 3. Despite the wide-ranging beneficial health effects of H2S demonstrated in 
preclinical models (Zhang et al., 2013, Predmore and Lefer, 2010), the mechanisms of regulation 
of endogenous H2S production remain incompletely understood. This is explained in part by the 
fact that pleiotropic benefits of endogenous H2S have emerged relatively recently in the 
experimental literature, and in part because the various methods to measure H2S itself remain 
non-specific, insensitive and/or inconvenient (Wang, 2012). 
Much of the existing literature on regulation of CBS and CGL is in the context of the TSP and de 
novo cysteine synthesis rather than H2S production per se. Nonetheless, in addition to our study 
on the regulation of CGL and CBS expression and H2S production by dietary restriction (DR) or 
protein restriction (PR) in multiple tissues and organisms (Hine et al., 2015), and the requirement 
for the mTORC1 repressor TSC in this process (Chapter 3), several other interventions have 
been shown to modulate TSP activity, and in some cases, H2S production. For example, low 
levels of sulfur amino acids (SAA: cysteine and methionine) increase the activity of the 
transsulfuration pathway (TSP) in cultured cells (Stipanuk and Ueki, 2011). Hypoxia increases 
CBS expression (Takano et al., 2014), but can result in H2S accumulation via reduced activity of 
oxygen-dependent H2S-detoxifying enzymes (Olson, 2015). Statins upregulate CGL expression 
and H2S production (Xu et al., 2014). Finally, altered CGL expression has been observed in a 
number of different disease states, however the data on the direction of the alterations is 
sometimes contradictory, and the effects on H2S production not well characterized (Zhao et al., 
2014).  
Regulation of H2S production by CGL and CBS occurs at multiple levels including 
transcriptional, post-transcriptional, post-translational and at the substrate level. Multiple 
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transcription factors have been implicated in the transcriptional regulation of the Cgl gene, 
including SP1 (Yang et al., 2011, Ishii et al., 2004, Yin et al., 2012), ATF4 (Dickhout et al., 
2012), ELK1 and NRF2 (Zhao et al., 2014). The PI3K/AKT pathway positively regulates Cgl 
expression via SP1 (Xu et al., 2014, Yin et al., 2012). In mouse embryonic fibroblasts, ATF4 
deficiency results in a baseline reduction of Cgl expression (Dickhout et al., 2012), while Cbs is 
transcriptionally upregulated by HIF upon hypoxia (Takano et al., 2014).  
Both CGL and CBS are also regulated post-transcriptionally and allosterically by a number of 
different mechanisms.  For example, Cgl expression is regulated post-transcriptionally by 
multiple microRNAs, and post-translationally by fluxes in intracellular calcium levels (Zhao et 
al., 2014). CBS contains a heme group, and its activity is regulated by redox state (Mathew et al., 
2011). Additionally, CBS contains an S-adenosylmethionine (SAM) binding site, which acts as a 
co-substrate and regulates its activity (Huang and Moore, 2015). Both CGL and CBS require 
pyridoxal-5'-phosphate (PLP) as a cofactor for their activity (Huang and Moore, 2015). 
Similar to DR, reduced signaling through growth hormone (GH)/insulin-like growth factor (IGF) 
axis is well established as an evolutionarily conserved mechanism of extended longevity. Dwarf 
mice with mutant GH/IGF axis are long-lived and stress resistant (Bartke and Brown-Borg, 2004, 
Brown-Borg, 2009). In order to investigate if increased H2S production can be a common 
downstream mechanism that mediates increased longevity in these two different well-established 
models, we decided to test H2S production in response to GH stimulation.  
Adequate substrate is also required for H2S production. Although CGL is a fairly promiscuous 
enzyme that can use many substrates, including cystathionine and homocysteine, cysteine is 
thought to be the primary substrate for endogenous H2S production in mammals (Zhao et al., 
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2014). However, the notion that cysteine deprivation increases TSP gene expression and de novo 
cysteine production, but also increases the degradation of cysteine by CGL for H2S production 
(Hine et al., 2015), presents an apparent paradox. Indeed, it is counterintuitive that the product of 
de novo cysteine production by CGL would then be used as the substrate for H2S generation by 
the same enzyme. However, de novo cysteine biosynthesis is not the only cellular source of free 
cysteine for H2S generation. Here we investigated the potential of autophagy as a source of free 
cysteine for H2S generation as an alternative explanation to this apparent paradox. 
 
RESULTS 
GROWTH HORMONE NEGATIVELY REGULATES H2S PRODUCTION 
A reduction in circulating growth factors, including insulin and IGF-1, is one of the most 
pronounced differences observed in mice under dietary protein restriction (Harputlugil et al., 
2014). In order to model the effects of nutrient deprivation on hepatic H2S production in a 
tractable in vitro system, we chose to culture mouse primary hepatocytes under conditions of 
reduced sulfur amino acid content (methionine/cysteine deprivation, or Met/Cys-) as well as 
reduced growth factor availability via serum deprivation (Serum-). We observed that Met/Cys 
deprivation, especially when combined with serum deprivation, resulted in a marked increase in 
Cgl mRNA levels; a similar trend was observed with serum deprivation alone (Figure 4.1A). On 
the other hand, Cbs mRNA levels were only mildly affected upon serum and Met/Cys 
deprivation, consistent with previous findings (Hine et al., 2015). Protein levels of CGL were 
increased by Met/Cys deprivation as well as serum deprivation, while CBS levels were increased 
by serum deprivation only (Figure 4.1B). Interestingly, serum deprivation, but not Met/Cys  
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Figure 4.1 Growth hormone negatively regulates H2S production. 
(A) mRNA levels of Cgl and Cbs in primary hepatocytes cultured in the indicated media 
conditions overnight. Levels were normalized to 18S. n = 3, Statistical significance of the 
difference relative to the Complete group was assessed by a Student’s t-test; *p<0.05, 
***p<0.0005. (EH) 
(B) Immunoblots of whole cell lysates from primary hepatocytes cultured in the indicated media 
conditions overnight. (EH) 
(C) H2S production capacity of primary hepatocytes cultured in the indicated media conditions 
overnight. Cells were exposed to lead-acetate paper overnight following treatments. (EH) 
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Figure 4.1 (Continued) 
(D) Immunoblots of whole cell lysates from primary hepatocytes treated with increasing doses of 
GH overnight as indicated in the presence of dialyzed FBS. (EH) 
(E) Igf-1 mRNA levels as determined by qPCR in primary hepatocytes treated as indicated for 24 
hours. n = 3, Statistical significance of the difference between vehicle (-GH) and GH treatment 
within cell culture was assessed by a Student’s t-test; *p < 0.05, ** p<0.01. (EH) 
(F) H2S production capacity of primary hepatocytes after 6 hours pretreatment with the indicated 
media and GH, overnight exposure to lead-acetate paper. (EH) 
(G) H2S production as measured by P3 probe fluorescence in primary hepatocytes cultured in the 
indicated media with or without GH overnight, followed by 1-hour incubation with P3 (green); 
10x objective used. (EH, CH) 
Data in all panels are shown as means ± SD. 
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deprivation, resulted in a marked increase in H2S production capacity as measured by the lead 
sulfide method (Figure 4.1C). Based on these data, we focused on the role of serum deprivation 
in increased H2S production, and the relevant growth factors in serum that might be responsible 
for this effect. 
Given critical unpublished data from our lab showing increased H2S production capacity in livers 
of long-lived hypopituitary Snell dwarf mice lacking GH secretion, as well as in engineered GH 
receptor KO mice, we decided to explore the potential role of GH in control of H2S production in 
primary hepatocytes in vitro. Phosphorylation of the transcription factor Stat5 and Igf-1 
transcription, markers of canonical GH action in the liver (Chia, 2014), were used to establish the 
dose response of primary hepatocytes to porcine GH. As 1 µg/ml GH was able to activate the 
downstream signaling and transcription pathways in primary hepatocytes (Figure 4.1D, 4.1E), 
this concentration was used for further experiments.  
Consistent with GH as a negative regulator of H2S production, we observed that GH treatment 
suppressed the increase in H2S production capacity observed upon serum deprivation using the 
lead sulfide method (Figure 4.1F). We also confirmed this result using a different methodology 
in which H2S binds specifically to a non-toxic probe (P3) in a 1-1 ratio and becomes fluorescent 
(Singha et al., 2015), which allows for visualization of H2S using 2-photon microscopy (Figure 
4.1G) or quantitation directly using a plate reader. Importantly, this latter methodology does not 
require the addition of cysteine as substrate, and thus is a more accurate readout of endogenous 
H2S production. Taken together, these data indicate that GH negatively regulates H2S production 
in vitro in primary hepatocytes, and thus is likely one of the factors in serum whose absence 
results in increased H2S production. 
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REGULATION OF H2S PRODUCTION BY GH IN VITRO INDEPENDENT OF CGL 
TRANSCRIPTIONAL REGULATION  
We next investigated the downstream mechanisms of GH-mediated suppression of H2S 
production in primary hepatocytes. In Snell and GHRKO mice lacking GH signaling, our 
unpublished observations indicate a significant increase in hepatic Cgl mRNA expression in vivo 
concomitant with increased H2S production capacity (data not shown). Interestingly, however, 
we did not see a meaningful impact of GH on Cgl and Cbs mRNA or protein levels in 
hepatocytes in vitro (Figure 4.2A, 4.2B). 
Nonetheless, when downstream GH receptor signaling was blocked by Jak2 inhibitors AZD1480 
or Fedratinib, H2S production was moderately increased in hepatocytes cultured in complete 
media with additional GH  (Figure 4.2C). Furthermore, the increase in H2S production induced 
by serum deprivation and blocked by GH was partially restored by Jak2 inhibition, suggesting 
that GH can act through the Jak2/Stat5 pathway to regulate H2S production. Igf-1 transcript 
levels were used as a control for GH signaling activity (Figure 4.2D). Consistent with previous 
experiments, Cgl or Cbs transcription did not correlate with observed changes in H2S production 
(Figure 4.2D).  
To further investigate the mechanism of GH inhibition of H2S production independent of Cgl 
transcriptional regulation, we analyzed the time frame in which serum or Met/Cys deprivation 
increased H2S production. In primary hepatocytes, one hour of serum or Met/Cys deprivation 
was sufficient to significantly increase endogenous H2S production as measured by P3 
fluorescence and quantitated in a plate reader (Figure 4.2E, 4.2F). Taken together, these findings 
support GH as a negative regulator of H2S production in vitro likely through at least two distinct 
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Figure 4.2 Regulation of H2S production by GH in vitro independent of Cgl transcriptional 
regulation. 
(A) Cgl and Cbs mRNA levels in primary hepatocytes that were cultured for 24 hours in the 
absence of serum (Serum-) and/or treated with vehicle (V) or 1 µg/ml GH as indicated. (EH) 
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Figure 4.2 (Continued) 
(B) Immunoblots of primary hepatocytes that were cultured for 24 hours in the absence of serum  
(Serum-) and/or treated with vehicle or 1 µg/ml GH as indicated. (EH) 
(C) Representative fluorescent images of H2S-specific P3 fluorescence in primary hepatocytes 
cultured overnight in the absence of serum (Serum-) and/or with vehicle (V) or Jak2 inhibitors 
AZD1480 or fedratinib as indicated. P3 probe was added to cells 1 hour before fixation/imaging; 
10x objective used. (EH, CH) 
(D) mRNA levels of Igf-1, Cgl and Cbs in primary hepatocytes upon overnight treatment with 
Jak2 inhibitors AZD1480 or Fedratinib in complete media. (EH) 
(E, F) H2S production as measured by P3 probe fluorescence intensity in primary hepatocytes 
cultured for 1 hour in the indicated media and quantified from 2-photon microscopic images (E) 
or using a plate reader (F). Statistical significance relative to the Complete group was assessed 
by a Student’s t-test; *p<0.05, **p<0.001 ***p<0.0001. (EH, CH) 
Data in all panels are shown as means ± SD. 
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mechanisms, one involving a rapid effect through canonical GH receptor/Jak2 signaling 
independent of Cgl transcriptional regulation, and another possibly indirect mechanism involving 
transcriptional regulation of Cgl. Future experiments will be required to delineate the molecular 
details of these mechanisms by which GH suppresses H2S production. 
H2S INDUCTION BY GROWTH FACTOR/SAA DEPRIVATION REQUIRES 
FUNCTIONAL AUTOPHAGY  
Previously we found that DR, PR or SAA restriction increases expression of the TSP enzyme 
CGL linked to increased de novo cysteine synthesis, consistent with the ability of mammalian 
cells to produce non-essential amino acids when they are limited in the diet. At the same time, 
we found SAA restriction increases cysteine degradation and H2S production by the same 
enzyme, CGL, resulting in an apparent paradox. A potential answer to this paradox lies in the 
fact that TSP-mediated de novo cysteine production is not the only way for a cell to obtain free 
cysteine when sulfur amino acids are limiting. Alternative strategies include salvage of cysteine 
from glutathione or breakdown of existing proteins via autophagy.  
To test the hypothesis that increased autophagy plays a role in generating the required substrate, 
free cysteine, for H2S production under DR/PR/SAA- conditions, we employed pharmacological 
and genetic inhibition of autophagy in three different cell types. In WT mouse primary 
hepatocytes and mouse embryonic fibroblasts (MEFs), chloroquine-mediated autophagy 
inhibition (confirmed by LC3B-II accumulation) resulted in a partial blockage of both serum- 
and serum- /Met/Cys- mediated increases in H2S production (Figure 4.3A, 4.3B, 4.3C). Atg5 and 
Atg7 knockout MEFs with defective autophagy also showed similarly  
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Figure 4.3 H2S induction by growth factor/SAA deprivation requires functional autophagy. 
(A) Immunoblots of primary hepatocytes cultured overnight as indicated. CQ: 10µM chloroquine. 
(EH) 
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Figure 4.3 (Continued) 
 (B) Representative images of H2S production measured by P3 probe fluorescence in primary 
hepatocytes cultured overnight as indicated. CQ: 10µM chloroquine; 10x objective used. (EH, 
CH) 
 (C) H2S production measured by P3 probe fluorescence using a plate reader in WT MEFs 
cultured overnight as indicated. CQ: 10µM chloroquine. (EH, CH) 
(D) Immunoblots of MEFs from WT, Atg5-/- and Atg7-/- backgrounds cultured in complete media. 
(EH) 
(E) H2S production measured by P3 probe fluorescence using a plate reader in MEFs of the 
indicated genotyped and cultured overnight as indicated. (EH, CH) 
(F) Immunoblots of stably transfected Hepa1-6 cells with sh-GFP, sh-Atg5 and sh-Atg7 under 
complete media conditions. (EH) 
(G) H2S production measured by P3 probe fluorescence using a plate reader in Hepa1-6 cells 
stably transfected with sh-GFP, sh-Atg5 and sh-Atg7 and cultured overnight as indicated. (EH, 
CH) 
Data in all panels are shown as means ± SD. 
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blunted H2S production upon serum deprivation (Figure 4.3D, 4.3E), A similar phenotype was 
observed in mouse liver-derived Hepa1-6 cells that were stably transfected with sh-Atg5 or sh-
Atg7, although to a lesser extent (Figure 4.3F, 4.3G). Taken together, these data indicate that 
serum/SAA deprivation mediated increase in H2S production requires functional autophagy.  
 
DISCUSSION 
Hydrogen sulfide has recently emerged as an important biological molecule with potent effects 
on stress resistance and general health, however the regulation of its endogenous production 
remains poorly understood. Our group recently described the importance of increased H2S 
production in dietary restriction-mediated stress resistance and longevity (Hine et al., 2015), 
revealing dietary sulfur amino acid intake as a regulator of endogenous H2S production. Here we 
investigated the possibility that H2S might be a common mediator of longevity extension and 
stress resistance in another well established model: reduced GH/IGF signaling. In support of this 
idea, we found that growth hormone (GH) is a negative regulator of H2S production in primary 
hepatocytes, possibly through post-translational mechanisms. Additionally we established that 
functional autophagy is required for induction of H2S production by serum starvation, suggesting 
additional substrate-level regulation of H2S production. 
On a cell-autonomous level, we found that H2S production could be stimulated using in vitro 
models of dietary restriction, including sulfur amino acid deprivation and/or serum deprivation, 
in multiple cell types (Hine et al., 2015) including mouse primary hepatocytes. Importantly, 
adding back GH into the media was able to partially reverse H2S production induced by serum 
deprivation, an effect that was partially dependent on Jak2 activity.  
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However, even though serum and Met/Cys deprivation induced mRNA and protein levels of 
CGL, the effect of GH on H2S production is unlikely to occur solely, or even primarily, on a 
transcriptional level. Indeed, GH treatment reduced Cgl mRNA levels only by ~20%, and did not 
have a detectable effect on CGL protein levels.  
Interestingly, other studies in our lab have shown that in vivo models of GH signaling deficiency, 
such as Snell dwarf and GHRKO mice, demonstrate significantly increased hepatic expression of 
CGL on both mRNA and protein levels, as well as increased H2S production capacity (data not 
shown). The reason for this discrepancy between the in vivo and in vitro models remains to be 
elucidated, but likely points to distinct mechanisms of CGL regulation by GH. Based on the 
rapid induction of H2S production upon serum withdrawal, activation is likely to occur at the 
post-translational level, and possibly also due to changes in substrate availability. Several post-
translational mechanisms of CGL activation have previously been reported (Zhao et al., 2014). 
Future studies are required in order to determine if GH affects any of these. In support of the 
potential role of increased substrate availability upon GH withdrawal, as discussed below we 
found a requirement for autophagy in H2S induction, which is also increased upon serum 
withdrawal (Bodemann et al., 2011). 
The observation that endogenous H2S production is increased under dietary or protein restricted 
conditions in vivo is potentially paradoxical, since under the same conditions the major substrate 
for H2S production by CGL, cysteine, is also limited. Furthermore, the increase in CGL 
expression under conditions of limited cysteine intake has heretofore been interpreted as 
evidence of increased de novo synthesis of cysteine from methionine via the TSP (Stipanuk and 
Ueki, 2011, Hine et al., 2015), which at face value appears more logical than increased H2S 
production requiring a further reduction in free cysteine levels. Nonetheless, de novo cysteine 
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biosynthesis from methionine, which is also limited upon protein restriction, is not the only 
source of free cysteine. 
Here we tested the hypothesis that the source of cysteine for H2S production under conditions of 
nutrient/growth factor limitation is degradation of proteins via autophagy. Indeed, we found that 
induction of H2S production upon serum deprivation was blocked by pharmacological or genetic 
inhibition of autophagy. The degree of requirement for autophagy varied by cell type, which 
might be because of differing levels of baseline and induced autophagy in these different cells. 
Sulfur amino acid deprivation and serum deprivation have been shown to induce autophagy in 
different cell types by others (Liu et al., 2015, Bodemann et al., 2011), however this remains to 
be investigated in these specific cell types under our in vitro conditions. In addition to autophagy, 
it is also possible that other methods of protein degradation, for example via the proteasome, 
may also contribute to cysteine generation for H2S production. 
Autophagy has been implicated in longevity and stress resistance in many organisms (Bergamini 
et al., 2004, Dutta et al., 2013, Jiang et al., 2010, Papadakis et al., 2013, Wang et al., 2011), 
including as a mediator of dietary restriction benefits in many contexts (Bergamini et al., 2004, 
Jia and Levine, 2007). This has been mostly attributed to its effects on clearance of damaged 
proteins and organelles such as mitochondria (Ravikumar et al., 2010). Whether its role in H2S 
production is one of the mediators of its reported effects on longevity and stress resistance 
remains to be studied. Cells from long-lived dwarfs have increased levels of autophagy (Wang 
and Miller, 2012). It is also possible that there might be crosstalk between reduced GH signaling, 
increased autophagy and increased H2S production. Elucidation of the details of this circuitry 
will have broad implications both in terms of understanding the mechanisms underlying two of 
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the most common increased longevity models, as well as potential therapeutic applications in the 
future. 
 
MATERIALS AND METHODS 
Primary hepatocyte isolation, mammalian cell culture conditions and treatments 
Mouse primary hepatocytes were isolated via portal vein collagenase treatment (Liberase, 
Roche) followed by Percoll gradient centrifugation. Primary hepatocytes, Hepa1-6 cells and 
MEFs were cultured at 37°C, 20% O2 and 5% CO2 incubators. Hepa1-6 cells and MEFs were 
maintained in DMEM media with 10% FBS for standard culture, primary hepatocytes were 
cultured in William’s E media with 5% FBS. For serum deprivation and amino acid deprivation 
experiments, Methionine/Cysteine-free DMEM (GIBCO), and 10% dialyzed FBS (Invitrogen) 
were used. AZD1480 and Fedratinib were from Selleckchem, Chloroquine and GH (Porcine 
STH) were from Sigma. Lentiviral infections were done in the presence of 10% FBS and 8µg/ml 
Polybrene on two consecutive days. Infected Hepa1-6 cells were selected with 3µg/ml 
puromycin for 2 weeks before use, and maintained with 3µg/ml puromycin. 
Western Blotting 
Immunoblotting was performed as described in Chapter 2. Primary antibodies: Actin (#4970 Cell 
Signaling Technology), CGL (ab151769 Abcam), CBS (ab135626 Abcam), Total Stat5 (sc-835 
Santa Cruz), p-Stat5 (#9359 Cell Signaling Technology), LC3B (NB100-2220 Novus), Atg5 
(NB110-53818, Novus), Atg7 (Sigma, A2856-200UL), and secondary antibodies from Dako. 
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RNA isolation and quantitative PCR 
Total RNA isolation, cDNA synthesis and qRT-PCRs were performed as described in Chapter 2. 
Primer sequences for each gene are listed in Table 4.1. 
Table 4.1 qRT-PCR Primer sequences 
Gene Forward primer (5' !  3') Reverse primer (5' !  3') 
Hprt TTTCCCTGGTTAAGCAGTACAGCCC TGGCCTGTATCCAACACTTCGAGA 
18S CATGCAGAACCCACGACAGTA CCTCACGCAGCTTGTTGTCTA 
Cgl TTGGATCGAAACACCCACAAA AGCCGACTATTGAGGTCATCA 
Cbs GGGACAAGGATCGAGTCTGGA AGCACTGTGTGATAATGTGGG 
Igf-1 GCTTGCTCACCTTCACCAG CAACACTCATCCACAATGCC 
 
H2S assays 
Lead sulfide method 
For H2S measurements, equal numbers of cells were plated on 12-well plates. Following the 
experimental treatments, cells were supplemented with 10mM L-Cysteine and 10mM PLP. 
Lead-acetate papers were prepared by soaking filter paper (VWR) in 20mM lead acetate and 
vacuum drying. Lead-acetate paper was placed on top of the culture plate and the cells were 
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incubated at 37°C cell culture incubator until the brown colored lead sulfide precipitate started to 
become visible (typically O/N). 
P3 probe method 
The chemical H2S probe P3 (Singha et al., 2015) was a gift by the Kyo Han Ahn. P3 (10µM) was 
added to the cells 1 hour before fixation by methanol or detection by plate reader (excitation 
360nm, emission 528nm) or 2-photon microscopy (excitation at 880 nm). 
Statistical analyses 
Data in all charts are represented as means ± standard deviations (SD). Statistical analyses were 
performed as described in Chapter 2. 
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CHAPTER 5 
 
DISCUSSION AND FUTURE DIRECTIONS 
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INTRODUCTION 
This thesis explores the mechanisms of protection against surgical stress by short-term dietary 
protein restriction (dietary restriction: DR; protein restriction: PR). There is a substantial body of 
literature on the beneficial health effects of dietary restriction, as covered in detail in Chapter 1, 
including extended lifespan of model organisms and resistance against acute surgical damage 
(Gallinetti et al., 2013). Here we used a model of mouse hepatic ischemia reperfusion injury 
(IRI) to probe for the underlying nutritional and genetic requirements of dietary restriction 
benefits. We identified that the restriction of proteins, as opposed to calories per se, provided the 
most dramatic protection in this context (Harputlugil et al., 2014, Robertson et al., 2015), 
highlighting the importance of protein intake in dietary restriction.  
Given the critical role of dietary protein in DR-mediated stress resistance, we explored the role 
of two distinct amino acid sensing pathways, mechanistic target of rapamycin complex 1 
(mTORC1) and general control nonderepressible 2 (GCN2). We identified a genetic requirement 
for the mTORC1 repressor tuberous sclerosis complex (TSC) in PR-mediated protection against 
hepatic IRI (Harputlugil et al., 2014). Mechanistically, we identified two distinct downstream 
effectors of protection, increased pro-survival insulin/Akt signaling (Harputlugil et al., 2014) and 
increased hydrogen sulfide (H2S) production (Hine et al., 2015) (Figure 5.1). How PR mediates 
increased H2S production, including the role of growth factor signaling and autophagy in 
induction of H2S production, and how H2S acts to protect tissues from stress, remain to be 
elucidated, but have important implications for stress resistance as well longevity regulation. 
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Figure 5.1 Summary of findings. EAA: essential amino acid 
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NUTRITIONAL BASIS OF DIETARY RESTRICTION  
DR is loosely defined as reduced food intake without malnutrition. As explained in detail in 
Chapter 1, the underlying nutritional requirements of DR are not fully elucidated. Multiple 
studies from our lab (Peng et al., 2012, Robertson et al., 2015, Robertson and Mitchell, 2013) 
and others (Gallinetti et al., 2013) have highlighted that the source of calories does matter in DR 
benefits. Proteins and specific amino acids such as methionine have been reported to play a role 
in DR benefits beyond their caloric value using various model organisms and endpoints (Mair et 
al., 2005, Grandison et al., 2009, Orentreich et al., 1993, Miller et al., 2005, Levine et al., 2014, 
Piper et al., 2011, Solon-Biet et al., 2014, Pamplona and Barja, 2006). 
Even though it is unclear how stress resistance and longevity are connected, they are often 
observed together in models of aging and dietary restriction, together with other hallmarks of DR, 
such as improved metabolic fitness (Gallinetti et al., 2013). In this thesis, we used short-term 
dietary interventions and protection from hepatic IRI as an experimental model in which to probe 
the nutritional requirements that underlie DR benefits. We discovered that total protein 
restriction is the most potent intervention among those we have investigated (Harputlugil et al., 
2014), likely due to restriction of the sulfur amino acids methionine and cysteine, which result in 
upregulation of endogenous H2S production (Hine et al., 2015). 
Our experimental model consisting of short-term DR regimens (up to one week) followed by an 
acute stress (hepatic IRI) had a number of advantages over longevity studies typically used to 
study mechanisms underlying DR benefits. First, we were able to quickly test multiple dietary 
preconditioning regimens and identify roles of specific macronutrients, including essential amino 
acids, yielding clues as to underlying molecular pathways. Unlike longevity studies, this 
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experimental model system can be used in the future to investigate the detailed roles of any 
specific nutrient or combination of nutrients, even those required for long-term health and 
survival. For example, so far in this study we have only tested the role of total amino acid 
deprivation and the deprivation of individual essential amino acid tryptophan against hepatic IRI. 
The specific roles and genetic requirements for other essential amino acids will need to be tested 
separately. Importantly, since mTORC1 is mostly regulated by the branched chain amino acids 
(BCAA) leucine, isoleucine and valine (Gallinetti et al., 2013), it will be important to see if the 
deprivation of BCAA alone is enough to provide a similar level of protection against hepatic IRI. 
Second, our experimental model allows for investigation of the effects of different DR regimens 
on any acute endpoint of our choice, including a variety of metabolic endpoints such as insulin 
sensitivity and glucose tolerance. Despite these advantages, it still remains to be investigated 
whether the nutritional, genetic and molecular basis of short-term DR uncovered using this 
experimental model will extend to other DR endpoints such as longevity, or translate into 
clinically relevant examples of ischemia reperfusion injury including heart attack or stroke. Even 
though incomplete diets are not suitable for long-term survival, it is possible to investigate 
potentially beneficial health effects or longevity extension by titrating the amount of protein or 
essential amino acids to lower levels in mouse models to test the long-term consequences. While 
longevity and health benefits have been reported for some protein or specific amino acid 
(methionine, tryptophan) restriction regimens (Pamplona and Barja, 2006, Orentreich et al., 
1993), this has not been done in a comprehensive manner, and little is known about underlying 
molecular mechanism. 
If ongoing studies to demonstrate safety, feasibility and efficacy of short-term DR in humans are 
successful, there are immediate clinical needs to be met. Hepatic IRI presents a major challenge 
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during liver surgeries and transplants (Datta et al., 2013, Klune and Tsung, 2010). Ischemic 
damage to other organs is also one of the major complications of cardiovascular surgeries for 
which there is currently no standard mitigation strategy (Mitchell et al., 2013).  
With the exception of overnight fasting of patients to prevent aspiration pneumonia, there are 
currently no accepted pre-operative dietary guidelines (Robertson and Mitchell, 2013). In fact, 
there is even a trend in some countries particularly in Europe to avoid preoperative fasting 
altogether in favor of carbohydrate loading prior to surgery, in order to address the issues of 
post-operative hunger, thirst and insulin resistance (Diks et al., 2005, Soreide et al., 2005). 
Although the various health benefits of long-term DR observed in experimental model organisms 
are increasingly being established in humans (Cava and Fontana, 2013, Ravussin et al., 2015), 
adherence remains an enormous problem for most people, severely limiting its relevance in the 
clinic. The duration of restriction necessary for benefits of DR in humans remains unknown, but 
will have a major influence on feasibility in the pre-operative setting.  
GENETIC BASIS OF DIETARY RESTRICTION 
Dietary restriction is both the most effective and best studied interventional approach to lifespan 
extension in various species (Fontana et al., 2010). There have been many studies investigating 
the underlying genetic requirements for extended longevity in multiple organisms. As expected, 
mutations and interventions that result in reduced activity of nutrient sensing pathways such as 
insulin signaling and TOR were found to play roles (Fontana et al., 2010). Genetic 
downregulation of TOR or its direct targets extends lifespan in yeasts (Fabrizio et al., 2001, 
Kaeberlein et al., 2005), worms (Vellai et al., 2003, Jia et al., 2004), flies (Zid et al., 2009) and 
rodents (Selman et al., 2009, Wu et al., 2013), as well as pharmacological inhibition of mTORC1 
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in mice (Miller et al., 2014, Miller et al., 2011, Harrison et al., 2009, Lamming et al., 2012). 
However, there have not been any studies that directly investigate a genetic requirement for the 
TSC complex in mTORC1 downregulation in mammalian DR benefits before. 
Previously our group has shown that the amino acid sensor GCN2 plays a role in mediating the 
protective effects of single essential amino acid restricted diets against renal and hepatic IRI 
(Peng et al., 2012). Since GCN2KO mice were still protected from hepatic IRI by total amino 
acid deprivation (Chapter 2), we tested the role of mTORC1 pathway in that context. Here we 
provide the first evidence for the genetic requirement for Tsc1 in two beneficial effects of total 
protein restriction: improved insulin sensitivity and protection against hepatic IRI. Interestingly, 
tryptophan restriction alone did not require the TSC complex, suggesting that different 
mechanisms might be mediating the effects of individual amino acid and total protein deficient 
diets, via parallel action of GCN2 and mTORC1 pathways. As discussed earlier, the genetic 
requirements for other essential amino acid restricted diets such as leucine or all BCAAs require 
further investigation in order to shed further light on the roles of GCN2 and mTORC1. The fact 
that tryptophan restriction but not PR was able to precondition LTsc1KO mice is counterintuitive, 
since PR also incorporates tryptophan restriction. Our interpretation of this finding is that PR 
treatment of LTsc1KO mice results in a state that is even less advantageous in the context of 
acute stress and this overrides any potential beneficial effect coming from GCN2 activation in 
these mice. This interpretation is consistent with the data that hepatic insulin sensitivity and Akt 
signaling is worse in LTsc1KOs upon PR compared to their baseline complete diet conditions 
(Chapter 2); and similarly their hepatic H2S production capacity is lower than baseline (Chapter 
3). 
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Interestingly, unlike its longevity extending effects in mice, (Miller et al., 2014, Miller et al., 
2011, Harrison et al., 2009, Lamming et al., 2012) rapamycin was unable to protect mice from 
hepatic IRI, despite reducing hepatic mTORC1 signaling. This indicates that the reduction in 
hepatic mTORC1 by itself is not enough to exert the protective effects of PR against hepatic IRI. 
Similar to this finding, rapamycin was shown to be insufficient to recapitulate other beneficial 
effects of PR by others (Miller et al., 2013). Additionally, combining rapamycin treatment with 
PR resulted in an abrogation of PR-mediated protection from hepatic IRI. There are various 
reasons why rapamycin might be playing a negative role in our context. In Chapter 2, we 
explored the inhibitory effects of rapamycin on mTORC2, which results in hepatic insulin 
resistance. Additionally, rapamycin has other side effects, such as increased inflammation, which 
might also underlie its negative consequences in the context of IRI (Lamming et al., 2013). The 
divergence between rapamycin’s beneficial effects on longevity and neutral or even detrimental 
effects on hepatic IRI might be because the underlying mechanisms are different, with 
inflammation and insulin resistance potentially more critical in the hepatic IRI context, and S6K 
activity more critical in aging.  
Additionally, whether there is a genetic requirement for the TSC complex in other DR benefits or 
in other contexts (e.g. long-term DR) remains to be studied. Since hepatic Tsc1 knockout results 
in hepatocellular carcinoma in mice in the long term (Menon et al., 2012), it is not possible to 
test its genetic requirement for longevity extension. However, other endpoints that are closely 
associated with DR benefits and extended longevity can be explored. For instance, in this study 
we investigated the impact of PR on LTsc1KOs hepatic insulin resistance, however we did not 
test the whole body insulin or glucose tolerance in these mice. Such future studies will be 
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informative in understanding the specific contribution of hepatic TSC/mTORC1 in PR-mediated 
whole body glucose homeostasis. 
MOLECULAR MECHANISMS UNDERLYING DIETARY RESTRICTION BENEFITS 
Even though a reduction in activity of the nutrient sensing mTORC1 pathway is clearly involved 
in mediating beneficial DR effects, downstream effector mechanisms remain incompletely 
understood. mTORC1 regulates numerous growth-related processes in cells ranging from protein, 
lipid, and nucleotide synthesis to autophagy (Howell et al., 2013). One potential downstream 
effector of mTORC1 involved in longevity regulation is the ribosomal S6 kinase (S6K). In 
addition to mediating pro-growth signals, S6K also feeds back to inhibit insulin/IGF1 signaling. 
Genetic ablation of S6K improves insulin sensitivity and increases longevity in mice (Selman et 
al., 2009). Nonetheless, our data indicate that downregulation of mTORC1 alone is not sufficient 
to provide beneficial effects of PR against hepatic IRI, since rapamycin treatment, a powerful 
inhibitor of downstream S6K phosphorylation, did not result in a positive outcome (Chapter 2). 
On the contrary, combining PR with rapamycin treatment partially abrogated the preconditioning 
effects of PR, likely through its inhibition of mTOR complex 2 (mTORC2) signaling (Lamming 
et al., 2012, Lamming et al., 2013) as previously discussed. 
Like reduced mTORC1 activity, a reduction in signaling through the evolutionarily conserved 
growth hormone/insulin/insulin-like growth factor (IGF) axis is strongly associated with 
extended longevity. This nutrient sensing signal transduction pathway, also referred to as 
insulin/insulin-like signaling (IIS), senses the availability of systemic nutrients and regulates 
growth on the organismal level (Fontana et al., 2010). IIS is highly interconnected with the 
mTORC1 pathway via PI3K/Akt activation of mTORC1 and mTORC1/S6K-dependent feedback 
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inhibition of IIS (Howell and Manning, 2011). Also like reduced mTORC1 activity, reduced IIS 
and improved insulin sensitivity are hallmarks of dietary restriction. Here we demonstrated that 
improved insulin sensitivity upon PR, and subsequently increased insulin/Akt signaling after IRI, 
is one of the mechanisms by which PR protects tissues against surgical stress. This finding is 
consistent with previous studies demonstrating increased insulin signaling upon dietary protein 
restriction (Toyoshima et al., 2010), and the protective effects of insulin/Akt signaling against 
apoptosis and IRI damage (Fuglesteg et al., 2009, Jonassen et al., 2001, Liu et al., 2007). 
As discussed in Chapter 2, the role of improved insulin sensitivity and increased post-operative 
pro-survival Akt signaling, while significant, only accounts for a portion of the protection 
afforded by PR against hepatic IRI. We therefore investigated additional molecular mechanisms 
underlying PR benefits using a comparative approach between WT mice that are afforded PR 
benefits and liver-specific Tsc1 knockout (LTsc1KO) mice that are not. Using an unbiased 
metabolomics approach, we eventually identified increased H2S production as another significant 
contributor to PR-mediated protection (Hine et al., 2015). 
By what mechanism endogenously produced H2S protects cells from surgical stress is not 
completely understood. Work in our laboratory suggests the involvement of mitochondrial 
electron transport chain and the potential of H2S to serve as a source of electrons during in vitro 
ischemia (Hine et al., 2015), but further studies are required to establish if this holds true in vivo. 
H2S can act as an antioxidant, and antioxidants can protect from IRI (Datta et al., 2013). 
Interestingly, the adaptive increase in H2S production does not require the NRF2 transcription 
factor, which is a master regulator of multiple other antioxidant defense systems including 
glutathione and NQO1 (Hine et al., 2015). Another interesting physiological effect of H2S is 
vasodilation, as evidenced by genetic deficiency in endogenous H2S production leading to 
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hypertension (Yang et al., 2008). As vasodilation is protective in the context of ischemia, the 
effects of a DR-mediated increase in H2S production on the vasculature could be a common 
mechanism of protection of numerous organs and tissues, including liver, brain and the blood 
vessels themselves, from ischemic stress, but remains to be studied in vivo (Wang, 2012). H2S is 
also thought to modulate inflammation through effects on NFkB signal transduction. 
The mechanism by which H2S mediates its pro-longevity effects in lower organisms, while 
currently unknown, is hypothesized to involve modulation of similar pathways as described 
above, including antioxidant defense, energy metabolism and inflammation (Wen et al., 2013, 
Hine and Mitchell, 2015). The major molecular mechanism by which H2S is thought to mediate 
such changes is by modifying surface-exposed Cys residues of target proteins via a post-
translational modification known as sulfhydration (Mustafa et al., 2009). However, much work 
remains in order to identify sulfhydrated proteins that contribute to extended longevity or stress 
resistance. 
mTORC1 also negatively regulates the lysosomal protein degradation pathway known as 
autophagy which is activated under conditions of nutrient limitation (Russell et al., 2014). Genes 
involved in autophagy have been implicated in regulation of longevity in lower organisms (Jia 
and Levine, 2010). In yeast, chronological lifespan extension by methionine restriction requires 
autophagy (Ruckenstuhl et al., 2014), as does DR-mediated lifespan extension in C. elegans (Jia 
and Levine, 2007). Autophagy induction has also been shown to play a role in stress resistance in 
many systems, including renal and hepatic ischemia reperfusion injuries in mice (Wang et al., 
2011, Jiang et al., 2010). mTORC1 downregulation leads to increased autophagy (Laplante and 
Sabatini, 2009) and importantly, LTsc1KO mice have been shown to have defective autophagic 
flux (Menon et al., 2012).  
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 Despite abundant genetic evidence of a requirement for autophagy in multiple DR-mediated 
benefits, the mechanism by which autophagy impacts longevity and stress resistance remains 
poorly understood. Our finding that autophagy is required for the stimulation of H2S production 
(Chapter 4) is consistent with a novel role for increased H2S as a downstream mediator of 
autophagy benefits. Nonetheless, future studies are required in order to determine whether 
defective autophagy in LTsc1KOs plays a causative role in the lack of PR response in these mice, 
as well as to elucidate the relative importance of H2S generation in mediating the benefits of 
autophagy in vivo. If autophagy is important for H2S production in vivo, we would predict lower 
endogenous H2S levels in vivo in autophagy deficient genetic models and models of 
pharmacological autophagy inhibition on DR/PR. Furthermore, if H2S is an important effector 
molecule of autophagy, we would predict that supplementation with exogenous H2S will at least 
partially rescue acute stress resistance in autophagy-deficient models.  
REGULATION OF ENDOGENOUS H2S PRODUCTION 
Despite its wide ranging biological effects and potential therapeutic implications, the 
mechanisms underlying the regulation of endogenous H2S production are poorly understood 
(Hine and Mitchell, 2015). Our lab has demonstrated that multiple forms of dietary restriction, 
including total calorie restriction, protein restriction and sulfur amino acid restriction, result in 
increased hepatic H2S production, which is necessary and sufficient for the benefits of DR 
against hepatic IRI (Hine et al., 2015). Here we identified two novel mechanisms involved in the 
regulation of endogenous H2S production: growth hormone (GH) signaling and autophagy 
(Chapter 4).  
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We identified that GH negatively regulates H2S production in vitro and that this downregulation 
mostly occurs via post-transcriptional mechanisms. Even though overnight GH treatment of 
serum-deprived mouse primary hepatocytes resulted in a ~20% reduction in cystathionine $-lyase 
(Cgl) mRNA levels, we were unable to detect a decrease in CGL or cystathionine "-synthase 
(CBS) protein levels within the same time frame. Consistent with our findings of a GH-H2S 
connection, long-lived hypopituitary Snell dwarf mice lacking growth hormone have a 
metabolite profile consistent with increased TSP activity (Vitvitsky et al., 2013), and Ames 
dwarfs were shown to have increased methionine flux towards transmethylation and 
transsulfuration (Uthus and Brown-Borg, 2006). Further unpublished findings from our lab have 
shown that Snell dwarf and GHRKO mice have increased levels of hepatic Cgl mRNA and 
protein in vivo, as well as increased H2S production capacity (data not shown). Thus it appears 
that in addition to cell autonomous post-translation control of H2S production by GH in 
hepatocytes in vitro, transcriptional regulation of Cgl downstream of GH signaling may be 
important in vivo. It is possible that the differences between in vivo and in vitro models of GH 
withdrawal and stimulation lie in the timing of these treatments. Other possibilities include 
additional systemic modulators such as endocrine hormones lacking in the in vitro system, as 
well as the changes that occur while hepatocytes adopt to in vitro culture conditions. 
It is interesting and potentially paradoxical that while reduced insulin/Akt signaling induced by 
constitutive mTORC1 activation or liver-specific insulin receptor ablation results in low levels of 
H2S production (Chapter 3), reduced GH signaling which is also characterized by reduced 
insulin/IGF1 signaling led to increased H2S production (Chapter 4). The main effector of hepatic 
GH action in the periphery is IGF1, which is secreted mainly by the liver and acts through the 
PI3K/Akt pathway (Chia, 2014). Interestingly the PI3K/Akt pathway was shown to positively 
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regulate Cgl expression via the SP1 transcription factor (Yin et al., 2012), which is consistent 
with our findings with the LTsc1KO and LIrKO mice. Our interpretation of these seemingly 
contradictory findings is that liver H2S production is controlled by pathways which are 
downstream of GH signaling, but do not involve IGF/insulin signaling. 
The fact that two of the most established pro-longevity interventions, dietary restriction and 
reduced GH/IGF1 signaling, both involve upregulation of H2S production suggests that H2S 
might be a common effector underlying extended longevity and related phenotypes including 
stress resistance and metabolic fitness in these models. Whether this is true in additional 
longevity models, and if so how H2S leads to these pleiotropic effects, remains to be investigated. 
The requirement of H2S generating enzymes in models of reduced GH/IGF signaling can be 
investigated using genetic and pharmacological models in both lower organisms and rodents. For 
example, evaluation of surgical stress resistance in mouse models of reduced GH signaling was 
not tested here, but will yield critical insight into the functional significance of increased H2S in 
these mice. Furthermore, although the importance of increased endogenous H2S is clear for DR-
mediated stress resistance, the potential role of H2S in DR-mediated longevity and metabolic 
fitness remains to be established in mammals. Two tractable experimental approaches include 
combining long-term DR with either pharmacological (PAG) or genetic (CGLKO) inhibition of 
H2S production. Such experiments are predicted to provide insight into the extent and the 
importance of H2S beyond surgical stress resistance and longevity extension in lower organisms. 
FUTURE DIRECTIONS 
Here we used LTsc1KO mice as a tool to identify two mechanisms critical for the beneficial 
preconditioning effects of PR against hepatic IRI: improved insulin sensitivity and increased H2S 
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production capacity. The degree to which these two mechanisms may be interconnected, as well 
as whether there are additional mechanisms important for PR-mediated preconditioning, are 
interesting future directions that will shed further light on pleiotropic benefits of DR in stress 
resistance and longevity. 
We have not yet identified the exact mechanism by which DR/PR results in increased H2S 
production. Potential links include GCN2 activation and subsequent ATF4 stabilization upon 
amino acid deprivation, reduction in GH signaling upon reduced liver growth hormone receptor 
(GHR) levels, and/or increased autophagy upon PR. Studies in our lab have shown that amino 
acid mediated GCN2 activation occurs in the livers of mice upon short-term DR/PR, and this 
activation translates into ATF4 stabilization and increased expression of its transcriptional 
targets such as Asns (Peng et al., 2012, Harputlugil et al., 2014). ATF4 has also been implicated 
in the baseline transcription of Cgl gene (Dickhout et al., 2012). Whether ATF4 plays a role in 
DR/PR mediated transcriptional upregulation of Cgl and/or Cbs remains to be investigated, and 
if true, this would be one of the most obvious connections between DR/PR and increased H2S.  
Earlier studies from our lab (Peng et al., 2012), as well as unpublished data, show that short term 
DR/PR results in reduced levels of hepatic Ghr expression and a subsequent decrease in IGF 
levels in circulation. Based on our finding that GH signaling can regulate H2S production in vivo 
and in vitro (Chapter 4), reduced GH signaling upon DR/PR may be another mechanism of 
control of hepatic H2S production. It is not clear yet how exactly GH/Jak2 signaling 
downregulates endogenous H2S, nor if there is a connection to ATF4 as described above. 
Importantly, DR does not further increase longevity or insulin sensitivity of mice lacking GHR 
(Bonkowski et al., 2009), suggesting a common mechanism of action between these two pro-
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longevity intervetions in mammals. A similar experimental design may thus be useful in 
determining if H2S is a common mediator of such benefits. 
Finally, autophagy has been closely associated with DR benefits in multiple contexts (Bergamini 
et al., 2004) and has been shown to be required for DR-mediated lifespan extension in C. elegans 
(Jia and Levine, 2007). As discussed earlier in this chapter, it remains to be investigated whether 
autophagy is required for DR/PR mediated increase in H2S production in vivo, and its functional 
consequences on stress resistance in mice and increased longevity in the eat-2 C. elegans model 
of DR (Hine et al., 2015). Although C. elegans lacks growth hormone, the fact that both 
autophagy and H2S have been implicated in longevity extension in this model makes it a good 
working system to study the requirement for autophagy in longevity extension in the eat-2 DR 
model. 
In addition to all the potential links between DR/PR and regulation of CGL/endogenous H2S 
production discussed above, crosstalk amongst these potential pathways, namely mTORC1, GH, 
autophagy and other DR-related pathways not mentioned here (e.g. AMP activated kinase), and 
H2S regulation remains to be explored. DR has pleiotropic benefits that are mediated by various 
different mechanisms, and since H2S is also a molecule with a variety of effects and potential 
ways of regulation, it is reasonable to assume that DR-mediated regulation of H2S occurs at 
multiple levels. A significant amount of future research is required to delineate the details of this 
circuitry and potentially multiple other mechanisms of DR/PR-mediated stimulation of H2S 
production. 
Identification of the sensing mechanisms, signaling pathways, transcriptional, post-
transcriptional and post-translational control mechanisms that play a role in regulation of H2S 
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will have broad implications in many fields of biology. Abnormalities in H2S producing enzyme 
levels and H2S itself have been observed in many human disease states including ischemia-
reperfusion, asthma, atherosclerosis, cancer, colitis, wound healing, diabetes, neurodegenerative 
diseases and hypertension (Wang, 2012). The involvement of H2S in such diverse pathological 
conditions have inspired efforts to design therapeutic applications of exogenous H2S in some of 
these conditions. There are multiple H2S donor molecules that can be used to deliver H2S to 
tissues, and exogenous administration of H2S thus presents exciting new therapeutic 
opportunities (Predmore and Lefer, 2010). However, there are also considerations around the use 
of exogenous H2S, since it is a toxic substance at high doses, and dosage and bioavailability 
might become issues with long-term use. For these reasons, the stimulation of its endogenous 
production may provide a safer alternative for its therapeutic use. As we have shown, short-term 
DR and PR present safe alternatives for inducing the endogenous production of H2S in mouse 
tissues. Such an approach may also solve the potential problems around delivery. Therefore, 
pathways controlling endogenous H2S production, optimum dietary conditions for its stimulation 
and potential physiological and therapeutic outcomes all warrant further investigation.  
 
REFERENCES 
BERGAMINI, E., CAVALLINI, G., DONATI, A. & GORI, Z. 2004. The role of 
macroautophagy in the ageing process, anti-ageing intervention and age-associated diseases. Int 
J Biochem Cell Biol, 36, 2392-404. 
BONKOWSKI, M. S., DOMINICI, F. P., ARUM, O., ROCHA, J. S., AL REGAIEY, K. A., 
WESTBROOK, R., SPONG, A., PANICI, J., MASTERNAK, M. M., KOPCHICK, J. J. & 
BARTKE, A. 2009. Disruption of growth hormone receptor prevents calorie restriction from 
improving insulin action and longevity. PLoS One, 4, e4567. 
 154 
CAVA, E. & FONTANA, L. 2013. Will calorie restriction work in humans? Aging (Albany NY), 
5, 507-14. 
CHIA, D. J. 2014. Minireview: mechanisms of growth hormone-mediated gene regulation. Mol 
Endocrinol, 28, 1012-25. 
DATTA, G., FULLER, B. J. & DAVIDSON, B. R. 2013. Molecular mechanisms of liver 
ischemia reperfusion injury: insights from transgenic knockout models. World J Gastroenterol, 
19, 1683-98. 
DICKHOUT, J. G., CARLISLE, R. E., JEROME, D. E., MOHAMMED-ALI, Z., JIANG, H., 
YANG, G., MANI, S., GARG, S. K., BANERJEE, R., KAUFMAN, R. J., MACLEAN, K. N., 
WANG, R. & AUSTIN, R. C. 2012. The integrated stress response modulates cellular redox 
state via induction of cystathionine gamma-lyase: cross-talk between the integrated stress 
response and thiol metabolism. J Biol Chem. 
DIKS, J., VAN HOORN, D. E., NIJVELDT, R. J., BOELENS, P. G., HOFMAN, Z., 
BOURITIUS, H., VAN NORREN, K. & VAN LEEUWEN, P. A. 2005. Preoperative fasting: an 
outdated concept? JPEN J Parenter Enteral Nutr, 29, 298-304. 
FABRIZIO, P., POZZA, F., PLETCHER, S. D., GENDRON, C. M. & LONGO, V. D. 2001. 
Regulation of longevity and stress resistance by Sch9 in yeast. Science, 292, 288-90. 
FONTANA, L., PARTRIDGE, L. & LONGO, V. D. 2010. Extending healthy life span--from 
yeast to humans. Science, 328, 321-6. 
FUGLESTEG, B. N., TIRON, C., JONASSEN, A. K., MJOS, O. D. & YTREHUS, K. 2009. 
Pretreatment with insulin before ischaemia reduces infarct size in Langendorff-perfused rat 
hearts. Acta Physiol (Oxf), 195, 273-82. 
GALLINETTI, J., HARPUTLUGIL, E. & MITCHELL, J. R. 2013. Amino acid sensing in 
dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR. 
Biochem J, 449, 1-10. 
GRANDISON, R. C., PIPER, M. D. & PARTRIDGE, L. 2009. Amino-acid imbalance explains 
extension of lifespan by dietary restriction in Drosophila. Nature, 462, 1061-4. 
HARPUTLUGIL, E., HINE, C., VARGAS, D., ROBERTSON, L., MANNING, B. D. & 
MITCHELL, J. R. 2014. The TSC complex is required for the benefits of dietary protein 
restriction on stress resistance in vivo. Cell Rep, 8, 1160-70. 
HARRISON, D. E., STRONG, R., SHARP, Z. D., NELSON, J. F., ASTLE, C. M., FLURKEY, 
K., NADON, N. L., WILKINSON, J. E., FRENKEL, K., CARTER, C. S., PAHOR, M., 
JAVORS, M. A., FERNANDEZ, E. & MILLER, R. A. 2009. Rapamycin fed late in life extends 
lifespan in genetically heterogeneous mice. Nature, 460, 392-5. 
HINE, C., HARPUTLUGIL, E., ZHANG, Y., RUCKENSTUHL, C., LEE, B. C., BRACE, L., 
LONGCHAMP, A., TREVINO-VILLARREAL, J. H., MEJIA, P., OZAKI, C. K., WANG, R., 
 155 
GLADYSHEV, V. N., MADEO, F., MAIR, W. B. & MITCHELL, J. R. 2015. Endogenous 
hydrogen sulfide production is essential for dietary restriction benefits. Cell, 160, 132-44. 
HINE, C. & MITCHELL, J. R. 2015. Calorie restriction and methionine restriction in control of 
endogenous hydrogen sulfide production by the transsulfuration pathway. Exp Gerontol, 68, 26-
32. 
HOWELL, J. J. & MANNING, B. D. 2011. mTOR couples cellular nutrient sensing to 
organismal metabolic homeostasis. Trends Endocrinol Metab, 22, 94-102. 
HOWELL, J. J., RICOULT, S. J., BEN-SAHRA, I. & MANNING, B. D. 2013. A growing role 
for mTOR in promoting anabolic metabolism. Biochem Soc Trans, 41, 906-12. 
JIA, K., CHEN, D. & RIDDLE, D. L. 2004. The TOR pathway interacts with the insulin 
signaling pathway to regulate C. elegans larval development, metabolism and life span. 
Development, 131, 3897-906. 
JIA, K. & LEVINE, B. 2007. Autophagy is required for dietary restriction-mediated life span 
extension in C. elegans. Autophagy, 3, 597-9. 
JIA, K. & LEVINE, B. 2010. Autophagy and longevity: lessons from C. elegans. Adv Exp Med 
Biol, 694, 47-60. 
JIANG, M., LIU, K., LUO, J. & DONG, Z. 2010. Autophagy is a renoprotective mechanism 
during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am J Pathol, 176, 1181-92. 
JONASSEN, A. K., SACK, M. N., MJOS, O. D. & YELLON, D. M. 2001. Myocardial 
protection by insulin at reperfusion requires early administration and is mediated via Akt and 
p70s6 kinase cell-survival signaling. Circ Res, 89, 1191-8. 
KAEBERLEIN, M., POWERS, R. W., 3RD, STEFFEN, K. K., WESTMAN, E. A., HU, D., 
DANG, N., KERR, E. O., KIRKLAND, K. T., FIELDS, S. & KENNEDY, B. K. 2005. 
Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science, 310, 
1193-6. 
KLUNE, J. R. & TSUNG, A. 2010. Molecular biology of liver ischemia/reperfusion injury: 
established mechanisms and recent advancements. Surg Clin North Am, 90, 665-77. 
LAMMING, D. W., YE, L., KATAJISTO, P., GONCALVES, M. D., SAITOH, M., STEVENS, 
D. M., DAVIS, J. G., SALMON, A. B., RICHARDSON, A., AHIMA, R. S., GUERTIN, D. A., 
SABATINI, D. M. & BAUR, J. A. 2012. Rapamycin-induced insulin resistance is mediated by 
mTORC2 loss and uncoupled from longevity. Science, 335, 1638-43. 
LAMMING, D. W., YE, L., SABATINI, D. M. & BAUR, J. A. 2013. Rapalogs and mTOR 
inhibitors as anti-aging therapeutics. J Clin Invest, 123, 980-9. 
LAPLANTE, M. & SABATINI, D. M. 2009. mTOR signaling at a glance. J Cell Sci, 122, 3589-
94. 
 156 
LEVINE, M. E., SUAREZ, J. A., BRANDHORST, S., BALASUBRAMANIAN, P., CHENG, C. 
W., MADIA, F., FONTANA, L., MIRISOLA, M. G., GUEVARA-AGUIRRE, J., WAN, J., 
PASSARINO, G., KENNEDY, B. K., WEI, M., COHEN, P., CRIMMINS, E. M. & LONGO, V. 
D. 2014. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall 
mortality in the 65 and younger but not older population. Cell Metab, 19, 407-17. 
LIU, H. T., ZHANG, H. F., SI, R., ZHANG, Q. J., ZHANG, K. R., GUO, W. Y., WANG, H. C. 
& GAO, F. 2007. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk 
between PI3-K/Akt and JNKs. Sheng Li Xue Bao, 59, 651-9. 
MAIR, W., PIPER, M. D. & PARTRIDGE, L. 2005. Calories do not explain extension of life 
span by dietary restriction in Drosophila. PLoS Biol, 3, e223. 
MENON, S., YECIES, J. L., ZHANG, H. H., HOWELL, J. J., NICHOLATOS, J., 
HARPUTLUGIL, E., BRONSON, R. T., KWIATKOWSKI, D. J. & MANNING, B. D. 2012. 
Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in 
Mice. Sci Signal, 5, ra24. 
MILLER, R. A., BUEHNER, G., CHANG, Y., HARPER, J. M., SIGLER, R. & SMITH-
WHEELOCK, M. 2005. Methionine-deficient diet extends mouse lifespan, slows immune and 
lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and 
stress resistance. Aging Cell, 4, 119-25. 
MILLER, R. A., HARRISON, D. E., ASTLE, C. M., BAUR, J. A., BOYD, A. R., DE CABO, R., 
FERNANDEZ, E., FLURKEY, K., JAVORS, M. A., NELSON, J. F., ORIHUELA, C. J., 
PLETCHER, S., SHARP, Z. D., SINCLAIR, D., STARNES, J. W., WILKINSON, J. E., 
NADON, N. L. & STRONG, R. 2011. Rapamycin, but not resveratrol or simvastatin, extends 
life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci, 66, 191-201. 
MILLER, R. A., HARRISON, D. E., ASTLE, C. M., FERNANDEZ, E., FLURKEY, K., HAN, 
M., JAVORS, M. A., LI, X., NADON, N. L., NELSON, J. F., PLETCHER, S., SALMON, A. B., 
SHARP, Z. D., VAN ROEKEL, S., WINKLEMAN, L. & STRONG, R. 2013. Rapamycin-
Mediated Lifespan Increase in Mice is Dose and Sex-Dependent and Appears Metabolically 
Distinct from Dietary Restriction. Aging Cell. 
MILLER, R. A., HARRISON, D. E., ASTLE, C. M., FERNANDEZ, E., FLURKEY, K., HAN, 
M., JAVORS, M. A., LI, X., NADON, N. L., NELSON, J. F., PLETCHER, S., SALMON, A. B., 
SHARP, Z. D., VAN ROEKEL, S., WINKLEMAN, L. & STRONG, R. 2014. Rapamycin-
mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from 
dietary restriction. Aging Cell, 13, 468-77. 
MITCHELL, J. R., BECKMAN, J. A., NGUYEN, L. L. & OZAKI, C. K. 2013. Reducing 
elective vascular surgery perioperative risk with brief preoperative dietary restriction. Surgery, 
153, 594-8. 
MUSTAFA, A. K., GADALLA, M. M., SEN, N., KIM, S., MU, W., GAZI, S. K., BARROW, R. 
K., YANG, G., WANG, R. & SNYDER, S. H. 2009. H2S signals through protein S-
sulfhydration. Sci Signal, 2, ra72. 
 157 
ORENTREICH, N., MATIAS, J. R., DEFELICE, A. & ZIMMERMAN, J. A. 1993. Low 
methionine ingestion by rats extends life span. J Nutr, 123, 269-74. 
PAMPLONA, R. & BARJA, G. 2006. Mitochondrial oxidative stress, aging and caloric 
restriction: the protein and methionine connection. Biochim Biophys Acta, 1757, 496-508. 
PENG, W., ROBERTSON, L., GALLINETTI, J., MEJIA, P., VOSE, S., CHARLIP, A., CHU, T. 
& MITCHELL, J. R. 2012. Surgical stress resistance induced by single amino acid deprivation 
requires Gcn2 in mice. Sci Transl Med, 4, 118ra11. 
PIPER, M. D., PARTRIDGE, L., RAUBENHEIMER, D. & SIMPSON, S. J. 2011. Dietary 
restriction and aging: a unifying perspective. Cell Metab, 14, 154-60. 
PREDMORE, B. L. & LEFER, D. J. 2010. Development of hydrogen sulfide-based therapeutics 
for cardiovascular disease. J Cardiovasc Transl Res, 3, 487-98. 
RAVUSSIN, E., REDMAN, L. M., ROCHON, J., DAS, S. K., FONTANA, L., KRAUS, W. E., 
ROMASHKAN, S., WILLIAMSON, D. A., MEYDANI, S. N., VILLAREAL, D. T., SMITH, S. 
R., STEIN, R. I., SCOTT, T. M., STEWART, T. M., SALTZMAN, E., KLEIN, S., BHAPKAR, 
M., MARTIN, C. K., GILHOOLY, C. H., HOLLOSZY, J. O., HADLEY, E. C., ROBERTS, S. 
B. & GROUP, C. S. 2015. A 2-Year Randomized Controlled Trial of Human Caloric Restriction: 
Feasibility and Effects on Predictors of Health Span and Longevity. J Gerontol A Biol Sci Med 
Sci, 70, 1097-104. 
ROBERTSON, L. T. & MITCHELL, J. R. 2013. Benefits of short-term dietary restriction in 
mammals. Exp Gerontol, 48, 1043-8. 
ROBERTSON, L. T., TREVINO-VILLARREAL, J. H., MEJIA, P., GRONDIN, Y., 
HARPUTLUGIL, E., HINE, C., VARGAS, D., ZHENG, H., OZAKI, C. K., KRISTAL, B. S., 
SIMPSON, S. J. & MITCHELL, J. R. 2015. Protein and Calorie Restriction Contribute 
Additively to Protection from Renal Ischemia Reperfusion Injury Partly via Leptin Reduction in 
Male Mice. J Nutr, 145, 1717-27. 
RUCKENSTUHL, C., NETZBERGER, C., ENTFELLNER, I., CARMONA-GUTIERREZ, D., 
KICKENWEIZ, T., STEKOVIC, S., GLEIXNER, C., SCHMID, C., KLUG, L., SORGO, A. G., 
EISENBERG, T., BUTTNER, S., MARINO, G., KOZIEL, R., JANSEN-DURR, P., FROHLICH, 
K. U., KROEMER, G. & MADEO, F. 2014. Lifespan extension by methionine restriction 
requires autophagy-dependent vacuolar acidification. PLoS Genet, 10, e1004347. 
RUSSELL, R. C., YUAN, H. X. & GUAN, K. L. 2014. Autophagy regulation by nutrient 
signaling. Cell Res, 24, 42-57. 
SELMAN, C., TULLET, J. M., WIESER, D., IRVINE, E., LINGARD, S. J., CHOUDHURY, A. 
I., CLARET, M., AL-QASSAB, H., CARMIGNAC, D., RAMADANI, F., WOODS, A., 
ROBINSON, I. C., SCHUSTER, E., BATTERHAM, R. L., KOZMA, S. C., THOMAS, G., 
CARLING, D., OKKENHAUG, K., THORNTON, J. M., PARTRIDGE, L., GEMS, D. & 
WITHERS, D. J. 2009. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. 
Science, 326, 140-4. 
 158 
SOLON-BIET, S. M., MCMAHON, A. C., BALLARD, J. W., RUOHONEN, K., WU, L. E., 
COGGER, V. C., WARREN, A., HUANG, X., PICHAUD, N., MELVIN, R. G., GOKARN, R., 
KHALIL, M., TURNER, N., COONEY, G. J., SINCLAIR, D. A., RAUBENHEIMER, D., LE 
COUTEUR, D. G. & SIMPSON, S. J. 2014. The ratio of macronutrients, not caloric intake, 
dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell Metab, 19, 
418-30. 
SOREIDE, E., ERIKSSON, L. I., HIRLEKAR, G., ERIKSSON, H., HENNEBERG, S. W., 
SANDIN, R. & RAEDER, J. 2005. Pre-operative fasting guidelines: an update. Acta 
Anaesthesiol Scand, 49, 1041-7. 
TOYOSHIMA, Y., TOKITA, R., OHNE, Y., HAKUNO, F., NOGUCHI, T., MINAMI, S., 
KATO, H. & TAKAHASHI, S. 2010. Dietary protein deprivation upregulates insulin signaling 
and inhibits gluconeogenesis in rat liver. J Mol Endocrinol, 45, 329-40. 
UTHUS, E. O. & BROWN-BORG, H. M. 2006. Methionine flux to transsulfuration is enhanced 
in the long living Ames dwarf mouse. Mech Ageing Dev, 127, 444-50. 
VELLAI, T., TAKACS-VELLAI, K., ZHANG, Y., KOVACS, A. L., OROSZ, L. & MULLER, 
F. 2003. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature, 426, 620. 
VITVITSKY, V., MARTINOV, M., ATAULLAKHANOV, F., MILLER, R. A. & BANERJEE, 
R. 2013. Sulfur-based redox alterations in long-lived Snell dwarf mice. Mech Ageing Dev, 134, 
321-30. 
WANG, J. H., AHN, I. S., FISCHER, T. D., BYEON, J. I., DUNN, W. A., JR., BEHRNS, K. E., 
LEEUWENBURGH, C. & KIM, J. S. 2011. Autophagy suppresses age-dependent ischemia and 
reperfusion injury in livers of mice. Gastroenterology, 141, 2188-2199 e6. 
WANG, R. 2012. Physiological implications of hydrogen sulfide: a whiff exploration that 
blossomed. Physiol Rev, 92, 791-896. 
WEN, Y. D., WANG, H., KHO, S. H., RINKIKO, S., SHENG, X., SHEN, H. M. & ZHU, Y. Z. 
2013. Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial 
dysfunction and oxidative stress. PLoS One, 8, e53147. 
WU, J. J., LIU, J., CHEN, E. B., WANG, J. J., CAO, L., NARAYAN, N., FERGUSSON, M. M., 
ROVIRA, II, ALLEN, M., SPRINGER, D. A., LAGO, C. U., ZHANG, S., DUBOIS, W., 
WARD, T., DECABO, R., GAVRILOVA, O., MOCK, B. & FINKEL, T. 2013. Increased 
mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction 
of mTOR expression. Cell Rep, 4, 913-20. 
YANG, G., WU, L., JIANG, B., YANG, W., QI, J., CAO, K., MENG, Q., MUSTAFA, A. K., 
MU, W., ZHANG, S., SNYDER, S. H. & WANG, R. 2008. H2S as a physiologic vasorelaxant: 
hypertension in mice with deletion of cystathionine gamma-lyase. Science, 322, 587-90. 
YIN, P., ZHAO, C., LI, Z., MEI, C., YAO, W., LIU, Y., LI, N., QI, J., WANG, L., SHI, Y., QIU, 
S., FAN, J. & ZHA, X. 2012. Sp1 is involved in regulation of cystathionine gamma-lyase gene 
 159 
expression and biological function by PI3K/Akt pathway in human hepatocellular carcinoma cell 
lines. Cell Signal, 24, 1229-40. 
ZID, B. M., ROGERS, A. N., KATEWA, S. D., VARGAS, M. A., KOLIPINSKI, M. C., LU, T. 
A., BENZER, S. & KAPAHI, P. 2009. 4E-BP extends lifespan upon dietary restriction by 
enhancing mitochondrial activity in Drosophila. Cell, 139, 149-60. 
 
 
